azathioprine has been researched along with Anti-MuSK Myasthenia Gravis in 242 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Current myasthenia gravis guidelines recommend the use of azathioprine as first-line steroid sparing agent." | 9.41 | Methotrexate in generalized myasthenia gravis: a systematic review. ( Adiao, KJB; Prado, MB, 2023) |
| "Treatments of myasthenia gravis (MG) usually include immunosuppressants such as glucocorticoids, tacrolimus, and azathioprine (AZA)." | 9.12 | Cancer occurrence following azathioprine treatment in myasthenia gravis patients: A systematic review and meta-analysis. ( Jiang, B; Jin, T; Shi, T; Wang, M; Xu, B; Xu, L; Zhang, Z, 2021) |
| "Ten patients with myasthenia gravis were randomized to azathioprine or prednisone as the initial immunomodulating drug and followed for over one year." | 9.08 | Randomized trial of azathioprine or prednisone for initial immunosuppressive treatment of myasthenia gravis. ( Albers, JW; Bromberg, MB; Feldman, EL; Forshew, DA; Wald, JJ, 1997) |
| "From January 1983 to October 1990, 41 patients with generalised myasthenia gravis were randomly given either prednisone or azathioprine." | 9.07 | A randomised clinical trial comparing prednisone and azathioprine in myasthenia gravis. Results of the second interim analysis. Myasthenia Gravis Clinical Study Group. ( , 1993) |
| "We report azathioprine treatment of 41 patients with myasthenia gravis, with a follow-up of more than 3 yr." | 8.78 | Azathioprine in myasthenia gravis: observations in 41 patients and a review of literature. ( Djojoatmodjo, S; Kuks, JB; Oosterhuis, HJ, 1991) |
| "A 16-year-old woman with MG developed hair loss, pancytopenia, bloody diarrhea, and fever shortly after azathioprine treatment." | 8.12 | Alopecia and colon ulcers following azathioprine use in a patient with myasthenia gravis: A case report. ( Hsu, WY; Lin, LC; Lin, PC; Liu, YC, 2022) |
| "BACKGROUND Patients taking azathioprine (AZA) are very susceptible to development of cytomegalovirus (CMV) infection." | 8.02 | Cytomegalovirus-Associated Nephrotic Syndrome in a Patient with Myasthenia Gravis Treated with Azathioprine: A Case Report. ( Chen, M; Gu, X; Wang, Y; Xie, L; Xu, Y; Zhang, X, 2021) |
| "Azathioprine (AZA) is the most common immunosuppressive drug used to treat myasthenia gravis (MG)." | 7.96 | Myasthenia gravis and azathioprine treatment: Adverse events related to thiopurine S-methyl-transferase (TPMT) polymorphisms. ( Ducci, RD; Kay, CSK; Lorenzoni, PJ; Scola, RH; Werneck, LC; Zanlorenzi, MF, 2020) |
| "We investigated the association of single nucleotide polymorphisms (SNPs) in drug-metabolizing enzymes and transporters (DMETs) with the response to azathioprine (AZA) in patients affected by myasthenia gravis (MG) to determine possible genotype-phenotype correlations." | 7.85 | A novel ABCC6 haplotype is associated with azathioprine drug response in myasthenia gravis. ( Antozzi, C; Barzago, C; Bernasconi, P; Biancolini, D; Bonanno, S; Camera, G; Canioni, E; Colleoni, L; Foti, M; Frangiamore, R; Franzi, S; Galbardi, B; Kapetis, D; Maggi, L; Mantegazza, R, 2017) |
| "Azathioprine (AZA) is commonly used in myasthenia gravis (MG)." | 7.83 | Remission And relapse of myasthenia gravis on long-term azathioprine: An ambispective study. ( Behari, M; Goyal, V; Gupta, A; Shukla, G; Srivastava, AK, 2016) |
| "Azathioprine is used for immunosuppression in myasthenia gravis (MG)." | 7.81 | Brainstem lymphoma in a myasthenia gravis patient on azathioprine. ( Katirji, B; Termsarasab, P, 2015) |
| "Increased rates of NMSC (nonmelanoma skin cancer) have recently been reported in people with MG (myasthenia gravis) receiving azathioprine treatment." | 7.81 | Nonmelanoma skin cancer risk awareness in azathioprine-treated myasthenia gravis patients. ( McGuigan, C; McGurgan, IJ, 2015) |
| "To evaluate the association between the use of azathioprine and risk of cancer in patients with non-thymoma myasthenia gravis (MG) in a nationwide setting." | 7.79 | Use of azathioprine for non-thymoma myasthenia and risk of cancer: a nationwide case-control study in Denmark. ( Friis, S; Gaist, D; Hallas, J; Hansen, K; Jensen, PE; Pedersen, EG; Pottegård, A, 2013) |
| "While being treated with azathioprine and dexamethasone, a 21-year old man with myasthenia gravis suddenly developed rapidly progressing brown macules, predominantly on the trunk, palms and soles." | 7.78 | [Eruptive melanocytic nevi during azathioprine therapy in myasthenia gravis]. ( Braun, SA; Frank, J; Hanneken, S; Helbig, D, 2012) |
| " We report a case of Salmonella brain abscess in a patient with myasthenia gravis on chronic azathioprine therapy without any prior structural brain lesion." | 7.76 | Salmonella brain abscess in a patient on chronic azathioprine therapy for myasthenia gravis: report of an unusual case and review of literature in the postantibiotic era. ( Bollu, PC; Kumar, G; Litofsky, NS; Sahota, P; Soni, CR, 2010) |
| "Side effects of long-term use of azathioprine in myasthenia gravis are infrequently reported." | 7.71 | Prostatic involvement of a testicular lymphoma in a patient with myasthenia gravis on long-term azathioprine. ( Barthelmes, L; Seale, JR; Thomas, KJ, 2002) |
| "Opportunistic infections after long-term treatment with azathioprine (AZA) have not been noted in patients with myasthenia gravis (MG)." | 7.70 | [Myasthenia gravis. Opportunistic cytomegalovirus infection after long-term azathioprine therapy]. ( Büttner, U; Eisensehr, I; Spuler, S; von Appen, K; Witt, TN, 1999) |
| "Azathioprine is an established immunosuppressive agent in the treatment of myasthenia gravis." | 7.69 | [Myasthenic crisis caused by azathioprine-induced fever]. ( George, A; Nau, R; Tumani, H, 1997) |
| "We retrospectively evaluated results obtained from azathioprine (AZA) treatment on a selected sample of 40 patients affected by autoimmune myasthenia gravis (MG)." | 7.68 | Azathioprine as a single immunosuppressive drug in the treatment of myasthenia gravis. ( Cosi, V; Erbetta, A; Lombardi, M; Piccolo, G, 1993) |
| "Twenty-seven patients with myasthenia gravis have been treated with azathioprine in conjunction with pyridostigmine and prednisolone for a total of 138 patient years." | 7.68 | Long term treatment of myasthenia gravis with azathioprine. ( Fonseca, V; Havard, CW, 1990) |
| "A patient with myasthenia gravis is described who exhibited hypersensitivity including an apparent acute exacerbation of the underlying disorder when treated with azathioprine." | 7.67 | Hypersensitivity to azathioprine in myasthenia gravis. ( Corston, R; Watts, GF, 1984) |
| "Twenty-four patients with myasthenia gravis were treated with azathioprine." | 7.67 | Azathioprine in the treatment of myasthenia gravis. ( Cornblath, DR; Lisak, RP; Parry, GJ; Schatz, NJ; Witte, AS, 1984) |
| "A 52 year old man with myasthenia gravis and normal liver function was treated with neostigmine, prednisolone and azathioprine." | 7.67 | Portal hypertension secondary to azathioprine in myasthenia gravis. ( Fonseca, V; Havard, CW, 1988) |
| "In this uncontrolled study, 104 patients with generalized myasthenia gravis treated with azathioprine for a median period of 29 months (range, 1 month to 12 years) were surveyed for possible adverse reactions." | 7.67 | Azathioprine toxicity during long-term immunosuppression of generalized myasthenia gravis. ( Besinger, U; Heininger, K; Hohlfeld, R; Michels, M; Toyka, KV, 1988) |
| "Azathioprine may be tried for treatment of severe myasthenia gravis, in a dose of 2 mg/kg BW." | 7.67 | Immunosuppressive drugs: azathioprine in the treatment of myasthenia gravis. ( Matell, G, 1987) |
| "Azathioprine (AZA) is used increasingly in the treatment of selected patients with myasthenia gravis (MG)." | 7.67 | Monitoring azathioprine therapy in myasthenia gravis. ( Cornblath, DR; Lisak, RP; Schatz, NJ; Witte, AS, 1986) |
| "In 15 patients with myasthenia gravis who were in stable clinical remission while receiving azathioprine, we monitored disease severity and serial autoantibody titers before and after discontinuation of azathioprine." | 7.67 | Myasthenia gravis: reactivation of clinical disease and of autoimmune factors after discontinuation of long-term azathioprine. ( Besinger, UA; Gerhold, B; Heininger, K; Hohlfeld, R; Toyka, KV, 1985) |
| "Ten patients with myasthenia gravis (MG) were treated with weekly plasma exchange (PE) in combination with prednisone and azathioprine; 4 of the patients were treated with 3-6 PE alone, before instituting prednisone/azathioprine." | 7.66 | Time course of improved neuromuscular function following plasma exchange alone and plasma exchange with prednisone/azathioprine in myasthenia gravis. ( Miller, RG; Milner-Brown, HS, 1982) |
| "Experimental autoimmune myasthenia gravis (EAMG), induced in rabbits by injection of acetylcholine receptor (AChR) from Torpedo californica, was suppressed by appropriate treatment with hydrocortisone or with azathioprine." | 7.65 | Immunosuppression of experimental autoimmune myasthenia gravis by hydrocortisone and azathioprine. ( Abramsky, O; Aharonov, A; Fuchs, S; Tarrab-Hazdai, R, 1976) |
| "Prednisone was given at the lowest dose to manage MG symptoms and adjusted as required according to protocol." | 6.76 | A single-blinded trial of methotrexate versus azathioprine as steroid-sparing agents in generalized myasthenia gravis. ( Badri, M; Bateman, K; Heckmann, JM; Rawoot, A; Renison, R, 2011) |
| "Azathioprine (Aza) has been used alone or in combination with steroids for two groups of myasthenic patients." | 6.66 | Azathioprine as a single drug or in combination with steroids in the treatment of myasthenia gravis. ( Antozzi, C; Cornelio, F; Mantegazza, R; Peluchetti, D; Sghirlanzoni, A, 1988) |
| "Azathioprine is an immunosuppressive medication used in the management of many autoimmune conditions." | 6.50 | Azathioprine-induced hepatitis and cholestasis occurring 1 year after treatment. ( Alam, S; Black, M; Chertoff, J; Elgendy, IY, 2014) |
| "Azathioprine (AZA) has been shown to be effective for MG with a significant steroid-sparing activity, although burdened by side effects." | 5.62 | Methotrexate as a Steroid-Sparing Agent in Myasthenia Gravis: A Preliminary Retrospective Study. ( Bonanno, C; Brizzi, T; Lupica, A; Musumeci, O; Nicocia, G; Pugliese, A; Rodolico, C; Toscano, A; Trimarchi, G, 2021) |
| "Azathioprine (AZA) is an immunosuppressant frequently used for treatment of various autoimmune conditions, including MG." | 5.43 | A Review of Azathioprine-Associated Hepatotoxicity and Myelosuppression in Myasthenia Gravis. ( Hulley, D; Jack, KL; Koopman, WJ; Nicolle, MW, 2016) |
| "Current myasthenia gravis guidelines recommend the use of azathioprine as first-line steroid sparing agent." | 5.41 | Methotrexate in generalized myasthenia gravis: a systematic review. ( Adiao, KJB; Prado, MB, 2023) |
| "Treatments of myasthenia gravis (MG) usually include immunosuppressants such as glucocorticoids, tacrolimus, and azathioprine (AZA)." | 5.12 | Cancer occurrence following azathioprine treatment in myasthenia gravis patients: A systematic review and meta-analysis. ( Jiang, B; Jin, T; Shi, T; Wang, M; Xu, B; Xu, L; Zhang, Z, 2021) |
| " A patient with pemphigus vulgaris and myasthenia gravis was treated for approximately five years with the cholinomimetic Mestinon (pyridostigmine bromide), Imuran (azathioprine), and a topical corticosteroid gel before the need to introduce systemic glucocorticosteroids." | 5.11 | New approaches to the treatment of pemphigus. ( Grando, SA, 2004) |
| "Ten patients with myasthenia gravis were randomized to azathioprine or prednisone as the initial immunomodulating drug and followed for over one year." | 5.08 | Randomized trial of azathioprine or prednisone for initial immunosuppressive treatment of myasthenia gravis. ( Albers, JW; Bromberg, MB; Feldman, EL; Forshew, DA; Wald, JJ, 1997) |
| "From January 1983 to October 1990, 41 patients with generalised myasthenia gravis were randomly given either prednisone or azathioprine." | 5.07 | A randomised clinical trial comparing prednisone and azathioprine in myasthenia gravis. Results of the second interim analysis. Myasthenia Gravis Clinical Study Group. ( , 1993) |
| "Currently, limited evidence favors the use of corticosteroids, azathioprine, and mycophenolate mofetil in ocular myasthenia gravis." | 4.84 | Medical treatment options for ocular myasthenia gravis. ( Antonio-Santos, AA; Eggenberger, ER, 2008) |
| "We report azathioprine treatment of 41 patients with myasthenia gravis, with a follow-up of more than 3 yr." | 4.78 | Azathioprine in myasthenia gravis: observations in 41 patients and a review of literature. ( Djojoatmodjo, S; Kuks, JB; Oosterhuis, HJ, 1991) |
| "Azathioprine is a widely prescribed drug for patients with chronic inflammatory diseases such as myasthenia gravis or organ transplant recipients." | 4.31 | Azathioprine therapy induces selective NK cell depletion and IFN-γ deficiency predisposing to herpesvirus reactivation. ( Bamert, D; Becher, B; Cortés-Vicente, E; Ingelfinger, F; Kreutmair, S; Mundt, S; Reyes-Leiva, D; Rindlisbacher, L; Schreiner, B; Sethi, A; Sparano, C; Tugues, S; Widmer, CC; Zwicky, P, 2023) |
| "A 16-year-old woman with MG developed hair loss, pancytopenia, bloody diarrhea, and fever shortly after azathioprine treatment." | 4.12 | Alopecia and colon ulcers following azathioprine use in a patient with myasthenia gravis: A case report. ( Hsu, WY; Lin, LC; Lin, PC; Liu, YC, 2022) |
| "BACKGROUND Patients taking azathioprine (AZA) are very susceptible to development of cytomegalovirus (CMV) infection." | 4.02 | Cytomegalovirus-Associated Nephrotic Syndrome in a Patient with Myasthenia Gravis Treated with Azathioprine: A Case Report. ( Chen, M; Gu, X; Wang, Y; Xie, L; Xu, Y; Zhang, X, 2021) |
| "Azathioprine (AZA) is the most common immunosuppressive drug used to treat myasthenia gravis (MG)." | 3.96 | Myasthenia gravis and azathioprine treatment: Adverse events related to thiopurine S-methyl-transferase (TPMT) polymorphisms. ( Ducci, RD; Kay, CSK; Lorenzoni, PJ; Scola, RH; Werneck, LC; Zanlorenzi, MF, 2020) |
| "We report a case of a 40 year old female who presented with a three month history of headaches with a background of Myasthenia Gravis (MG), treated with azathioprine." | 3.88 | An unusual presentation of cerebellar lymphoma. ( Astradsson, A; Harley, B; Muthurajah, V; Shivapathasundram, G; Wickremesekera, A, 2018) |
| "We investigated the association of single nucleotide polymorphisms (SNPs) in drug-metabolizing enzymes and transporters (DMETs) with the response to azathioprine (AZA) in patients affected by myasthenia gravis (MG) to determine possible genotype-phenotype correlations." | 3.85 | A novel ABCC6 haplotype is associated with azathioprine drug response in myasthenia gravis. ( Antozzi, C; Barzago, C; Bernasconi, P; Biancolini, D; Bonanno, S; Camera, G; Canioni, E; Colleoni, L; Foti, M; Frangiamore, R; Franzi, S; Galbardi, B; Kapetis, D; Maggi, L; Mantegazza, R, 2017) |
| "Azathioprine (AZA) is commonly used in myasthenia gravis (MG)." | 3.83 | Remission And relapse of myasthenia gravis on long-term azathioprine: An ambispective study. ( Behari, M; Goyal, V; Gupta, A; Shukla, G; Srivastava, AK, 2016) |
| "Azathioprine is used for immunosuppression in myasthenia gravis (MG)." | 3.81 | Brainstem lymphoma in a myasthenia gravis patient on azathioprine. ( Katirji, B; Termsarasab, P, 2015) |
| "Increased rates of NMSC (nonmelanoma skin cancer) have recently been reported in people with MG (myasthenia gravis) receiving azathioprine treatment." | 3.81 | Nonmelanoma skin cancer risk awareness in azathioprine-treated myasthenia gravis patients. ( McGuigan, C; McGurgan, IJ, 2015) |
| "To evaluate the association between the use of azathioprine and risk of cancer in patients with non-thymoma myasthenia gravis (MG) in a nationwide setting." | 3.79 | Use of azathioprine for non-thymoma myasthenia and risk of cancer: a nationwide case-control study in Denmark. ( Friis, S; Gaist, D; Hallas, J; Hansen, K; Jensen, PE; Pedersen, EG; Pottegård, A, 2013) |
| "While being treated with azathioprine and dexamethasone, a 21-year old man with myasthenia gravis suddenly developed rapidly progressing brown macules, predominantly on the trunk, palms and soles." | 3.78 | [Eruptive melanocytic nevi during azathioprine therapy in myasthenia gravis]. ( Braun, SA; Frank, J; Hanneken, S; Helbig, D, 2012) |
| "We report two cases of stage IV malignant melanoma arising in patients treated with azathioprine for myasthenia gravis." | 3.76 | Regression of advanced melanoma upon withdrawal of immunosuppression: case series and literature review. ( Collichio, F; Dillon, P; Sharpless, N; Thomas, N, 2010) |
| " We report a case of Salmonella brain abscess in a patient with myasthenia gravis on chronic azathioprine therapy without any prior structural brain lesion." | 3.76 | Salmonella brain abscess in a patient on chronic azathioprine therapy for myasthenia gravis: report of an unusual case and review of literature in the postantibiotic era. ( Bollu, PC; Kumar, G; Litofsky, NS; Sahota, P; Soni, CR, 2010) |
| "We studied the long-term crisis-preventing effect of combined prednisolone-azathioprine (PR-AZA) treatment in myasthenia gravis (MG)." | 3.75 | Long-term effects of combined immunosuppressive treatment on myasthenic crisis. ( Illes, Z; Kasa, K; Komoly, S; Mikor, A; Rózsa, C, 2009) |
| "The preferred immunosuppressive drug for long term treatment of myasthenia gravis (MG) is azathioprine (AZA)." | 3.75 | Mycophenolate mofetil as second line immunosuppressant in Myasthenia gravis--a long-term prospective open-label study. ( Hanisch, F; Wendt, M; Zierz, S, 2009) |
| " Here we show that the number of Treg cells in the blood is significantly lower in untreated myasthenia gravis patients than in age-matched healthy subjects, whereas it is normal or elevated in patients on immunosuppressive therapy (prednisone frequently associated with azathioprine)." | 3.73 | Circulating and thymic CD4 CD25 T regulatory cells in myasthenia gravis: effect of immunosuppressive treatment. ( Battaglia, A; Buzzonetti, A; Ciaraffa, F; Evoli, A; Fattorossi, A; Scambia, G, 2005) |
| "The aim of this study was to evaluate the long-term adverse effect (AE) profile of azathioprine (AZA) plus methylprednisolone combined immunosuppressive treatment in myasthenia gravis (MG) in a larger patient cohort." | 3.73 | Safety of long-term combined immunosuppressive treatment in myasthenia gravis--analysis of adverse effects of 163 patients. ( Fornadi, L; Komoly, S; Lovas, G; Rozsa, C; Szabo, G, 2006) |
| "Side effects of long-term use of azathioprine in myasthenia gravis are infrequently reported." | 3.71 | Prostatic involvement of a testicular lymphoma in a patient with myasthenia gravis on long-term azathioprine. ( Barthelmes, L; Seale, JR; Thomas, KJ, 2002) |
| " Here we report the case of a patient with myasthenia gravis receiving long-term immunosuppression with azathioprine and recurrent well-differentiated thymic carcinoma who developed CD4+ T-cell depletion and CNS cryptococcosis after multiple courses of chemotherapy and mediastinal irradiation." | 3.70 | Late onset immunodeficiency in a patient with recurrent thymic carcinoma and myasthenia gravis. ( Padberg, F; Schmidt, S, 1998) |
| "Opportunistic infections after long-term treatment with azathioprine (AZA) have not been noted in patients with myasthenia gravis (MG)." | 3.70 | [Myasthenia gravis. Opportunistic cytomegalovirus infection after long-term azathioprine therapy]. ( Büttner, U; Eisensehr, I; Spuler, S; von Appen, K; Witt, TN, 1999) |
| "Azathioprine is an established immunosuppressive agent in the treatment of myasthenia gravis." | 3.69 | [Myasthenic crisis caused by azathioprine-induced fever]. ( George, A; Nau, R; Tumani, H, 1997) |
| "We report a case of broncho-alveolar carcinoma (CBA) in a man of 64 who had been treated with azathioprine for severe myasthenia gravis." | 3.68 | [Bronchiolo-alveolar carcinoma complicating myasthenia treated by azathioprine]. ( Chatté, G; Langevin, B, 1993) |
| "We retrospectively evaluated results obtained from azathioprine (AZA) treatment on a selected sample of 40 patients affected by autoimmune myasthenia gravis (MG)." | 3.68 | Azathioprine as a single immunosuppressive drug in the treatment of myasthenia gravis. ( Cosi, V; Erbetta, A; Lombardi, M; Piccolo, G, 1993) |
| "Twenty-seven patients with myasthenia gravis have been treated with azathioprine in conjunction with pyridostigmine and prednisolone for a total of 138 patient years." | 3.68 | Long term treatment of myasthenia gravis with azathioprine. ( Fonseca, V; Havard, CW, 1990) |
| "A patient with myasthenia gravis is described who exhibited hypersensitivity including an apparent acute exacerbation of the underlying disorder when treated with azathioprine." | 3.67 | Hypersensitivity to azathioprine in myasthenia gravis. ( Corston, R; Watts, GF, 1984) |
| "Twenty-four patients with myasthenia gravis were treated with azathioprine." | 3.67 | Azathioprine in the treatment of myasthenia gravis. ( Cornblath, DR; Lisak, RP; Parry, GJ; Schatz, NJ; Witte, AS, 1984) |
| "A 52 year old man with myasthenia gravis and normal liver function was treated with neostigmine, prednisolone and azathioprine." | 3.67 | Portal hypertension secondary to azathioprine in myasthenia gravis. ( Fonseca, V; Havard, CW, 1988) |
| "In this uncontrolled study, 104 patients with generalized myasthenia gravis treated with azathioprine for a median period of 29 months (range, 1 month to 12 years) were surveyed for possible adverse reactions." | 3.67 | Azathioprine toxicity during long-term immunosuppression of generalized myasthenia gravis. ( Besinger, U; Heininger, K; Hohlfeld, R; Michels, M; Toyka, KV, 1988) |
| "Azathioprine may be tried for treatment of severe myasthenia gravis, in a dose of 2 mg/kg BW." | 3.67 | Immunosuppressive drugs: azathioprine in the treatment of myasthenia gravis. ( Matell, G, 1987) |
| "In a selected group of 69 patients with myasthenia gravis treated with prednisone, the factors were studied that might have influenced the reoccurrence or exacerbation of clinical signs after initial improvement in two-thirds of the patients." | 3.67 | Factors influencing the relapse risk at steroid dose reduction in myasthenia gravis. ( Oosterhuis, HJ; Scherpbier, HJ, 1987) |
| "Azathioprine (AZA) is used increasingly in the treatment of selected patients with myasthenia gravis (MG)." | 3.67 | Monitoring azathioprine therapy in myasthenia gravis. ( Cornblath, DR; Lisak, RP; Schatz, NJ; Witte, AS, 1986) |
| "In 15 patients with myasthenia gravis who were in stable clinical remission while receiving azathioprine, we monitored disease severity and serial autoantibody titers before and after discontinuation of azathioprine." | 3.67 | Myasthenia gravis: reactivation of clinical disease and of autoimmune factors after discontinuation of long-term azathioprine. ( Besinger, UA; Gerhold, B; Heininger, K; Hohlfeld, R; Toyka, KV, 1985) |
| "We reviewed the records of 37 patients with myasthenia gravis treated with azathioprine (n = 10) or cyclophosphamide (n = 27)." | 3.67 | Immunosuppressive drug therapy in myasthenia gravis. ( Harati, Y; Niakan, E; Rolak, LA, 1986) |
| "Ten patients with myasthenia gravis (MG) were treated with weekly plasma exchange (PE) in combination with prednisone and azathioprine; 4 of the patients were treated with 3-6 PE alone, before instituting prednisone/azathioprine." | 3.66 | Time course of improved neuromuscular function following plasma exchange alone and plasma exchange with prednisone/azathioprine in myasthenia gravis. ( Miller, RG; Milner-Brown, HS, 1982) |
| "We have investigated whether plasma exchange in myasthenia gravis synergises with additional immunosuppressive drug therapy (azathioprine, cyclophosphamide or cytosine arabinoside)." | 3.66 | Plasma exchange and immunosuppressive drug treatment in myasthenia gravis: no evidence for synergy. ( Hawkey, CJ; Newsom-Davis, J; Vincent, A, 1981) |
| "6 years after resection and postirradiation of an "asymptomatic" thymoma, myasthenia gravis developed in a 46 year old man which improved within 6 months following initiation of immunosuppressive therapy with azathioprine." | 3.65 | [Problems of postthymectomy-syndromes, e.g. myasthenia gravis (author's transl)]. ( Fischer, K; Janzen, RW; Lachenmayer, L, 1977) |
| "Plasmapheresis combined with prednisone and azathioprine therapy produced striking clinical improvement in five patients with myasthenia gravis who still had moderate to severe disability despite thymectomy, high-dose prednisone therapy and optimal doses of cholinesterase inhibitors." | 3.65 | Plasmapheresis and immunosuppressive drug therapy in myasthenia gravis. ( Cassel, CK; Dau, PC; Denys, EH; Lindstrom, JM; Shev, EE; Spitler, LE, 1977) |
| "Experimental autoimmune myasthenia gravis (EAMG), induced in rabbits by injection of acetylcholine receptor (AChR) from Torpedo californica, was suppressed by appropriate treatment with hydrocortisone or with azathioprine." | 3.65 | Immunosuppression of experimental autoimmune myasthenia gravis by hydrocortisone and azathioprine. ( Abramsky, O; Aharonov, A; Fuchs, S; Tarrab-Hazdai, R, 1976) |
| "The tapering of prednisone therapy in generalized myasthenia gravis (MG) presents a therapeutic dilemma; however, the recommended regimen has not yet been validated." | 3.01 | Comparison of Corticosteroid Tapering Regimens in Myasthenia Gravis: A Randomized Clinical Trial. ( Birnbaum, S; Clair, B; Demeret, S; Eymard, B; Friedman, D; Grimaldi, L; Gueguen, A; Nadaj-Pakleza, A; Porcher, R; Sharshar, T; Spinazzi, M; Tranchant, C, 2021) |
| "Achondroplasia is the commonest skeletal dysplasia of autosomal dominant inheritance caused by "gain of function" mutations in the fibroblast growth factor receptor 3 (FGFR3) gene." | 2.82 | Myasthenia gravis complicating the surgical management of achondroplasia: a case-based update. ( Afshari, FT; Debenham, P; Parida, A; Solanki, GA, 2022) |
| "The tacrolimus trial was carried out in Japan on a relatively large number of patients (tacrolimus, 40; placebo, 40)." | 2.77 | [Recent clinical trials on treatment of myasthenia gravis]. ( Yoshikawa, H, 2012) |
| "Prednisone was given at the lowest dose to manage MG symptoms and adjusted as required according to protocol." | 2.76 | A single-blinded trial of methotrexate versus azathioprine as steroid-sparing agents in generalized myasthenia gravis. ( Badri, M; Bateman, K; Heckmann, JM; Rawoot, A; Renison, R, 2011) |
| "Mean azathioprine dose was reduced concomitantly from 89 +/- 9." | 2.70 | Long-term treatment of myasthenia gravis with immunoadsorption. ( Derfler, K; Goldammer, A; Haas, M; Mayr, N; Zeitlhofer, J, 2002) |
| "Azathioprine (Aza) has been used alone or in combination with steroids for two groups of myasthenic patients." | 2.66 | Azathioprine as a single drug or in combination with steroids in the treatment of myasthenia gravis. ( Antozzi, C; Cornelio, F; Mantegazza, R; Peluchetti, D; Sghirlanzoni, A, 1988) |
| "Azathioprine is an immunosuppressive medication used in the management of many autoimmune conditions." | 2.50 | Azathioprine-induced hepatitis and cholestasis occurring 1 year after treatment. ( Alam, S; Black, M; Chertoff, J; Elgendy, IY, 2014) |
| "Myasthenia gravis is a rare, auto-immune neuromuscular junction disorder." | 2.44 | [Myasthenia gravis]. ( Fleury, MC; Tranchant, C, 2008) |
| "Myasthenia gravis is probably the most thoroughly understood of all human autoimmune diseases." | 2.43 | Myasthenia gravis: emerging new therapy options. ( Sieb, JP, 2005) |
| "Myasthenia gravis is caused by antibodies against acetylcholine receptors and is treated with inhibition or elimination of antibody production." | 2.41 | [A case of myasthenia gravis, who developed minimal change nephrotic syndrome during immunosuppressive therapy after thymectomy]. ( Inoue, Y; Matsuda, O; Takahashi, K; Takemura, T; Yoshimura, A, 2000) |
| "Myasthenia gravis is a disorder characterized by weakness and fatigue of voluntary muscles." | 2.40 | Myasthenia gravis: clinical features, pathogenesis, evaluation, and medical management. ( Heitmiller, RF, 1999) |
| "Myasthenia gravis is an autoimmune disorder of neuromuscular transmission." | 2.39 | A practical guide to the recognition and management of myasthenia gravis. ( Batocchi, AP; Evoli, A; Tonali, P, 1996) |
| "Pregnancy is certainly an option open to patients with myasthenia gravis." | 2.38 | Myasthenia gravis and pregnancy. ( Burke, ME, 1993) |
| "Myasthenia gravis is discussed with reference to recent immunologic findings, improvements in diagnostic procedure, and therapy." | 2.36 | [Myasthenia gravis. New results on etiology, diagnosis and therapy]. ( Jerusalem, F, 1977) |
| "Azathioprine (AZA) has been shown to be effective for MG with a significant steroid-sparing activity, although burdened by side effects." | 1.62 | Methotrexate as a Steroid-Sparing Agent in Myasthenia Gravis: A Preliminary Retrospective Study. ( Bonanno, C; Brizzi, T; Lupica, A; Musumeci, O; Nicocia, G; Pugliese, A; Rodolico, C; Toscano, A; Trimarchi, G, 2021) |
| "Myasthenia gravis is an autoimmune disease caused by antibodies to acetylcholine receptors in the post-junctional membrane of the neuromuscular junction." | 1.62 | Visceral leishmaniasis masquerading as drug-induced pancytopenia in myasthenia gravis. ( Azad, S; Bhattacharyya, D; Chattopadhya, D; Dhingra, G; Mohanty, A; Nath, UK, 2021) |
| "Seventy-six of 87 cases had persistent ophthalmoparesis." | 1.48 | Myasthenic ophthalmoparesis: Time To resolution after initiating immune therapies. ( Europa, TA; Heckmann, JM; Nel, M, 2018) |
| "Myasthenia gravis is an autoimmune condition where antibodies form against the acetylcholine receptors at the neuromuscular junction, eventually causing damage to the motor end plate." | 1.46 | Myasthenia Gravis and Its Aeromedical Implications. ( Jagathesan, T; O'Brien, MD, 2017) |
| "Azathioprine (AZA) is an immunosuppressant frequently used for treatment of various autoimmune conditions, including MG." | 1.43 | A Review of Azathioprine-Associated Hepatotoxicity and Myelosuppression in Myasthenia Gravis. ( Hulley, D; Jack, KL; Koopman, WJ; Nicolle, MW, 2016) |
| "Sweet syndrome is a reactive, sterile, pustular dermatosis that occurs in association with infection, malignancy, or connective tissue disease or in response to the use of certain medications." | 1.35 | Sweet syndrome as a manifestation of azathioprine hypersensitivity. ( Brunner, KL; El-Azhary, RA; Gibson, LE, 2008) |
| "Diplopia is frequently encountered in neurological practice and may occur as part of the clinical spectrum of 3rd cranial nerve palsy." | 1.35 | Third cranial nerve palsy or pseudo 3rd nerve palsy of myasthenia gravis? A challenging diagnosis in systemic lupus erythematosus. ( Appenzeller, S; Clarke, A; Veilleux, M, 2009) |
| "Only four patients with extrathymic tumors had an associated thymoma." | 1.33 | Extrathymic malignancies in patients with myasthenia gravis. ( Abramsky, O; Argov, Z; Ben Hur, T; Karussis, D; Levin, N; Lossos, A; Siegal, T, 2005) |
| "We conclude that as for the medical treatment of myasthenia gravis azathioprine plus steroid improves the outcome; and for the surgical treatment, early thymectomy should be performed in all generalize myasthenia patients." | 1.32 | Myasthenia gravis: how to treat? ( Akpinar, A; Karlikaya, G; Okay, T; Tireli, H; Tutkavul, K, 2004) |
| "The case of a patient with fatigable diplopia and ptosis 3 years after removal of a large-cell lung carcinoma is presented." | 1.31 | Myasthenia gravis with a paraneoplastic marker. ( Leavitt, JA, 2000) |
| " Remission, pharmacological remission, and marked improvement with reduction in drug dosage were considered good results." | 1.31 | Clinical characteristics and prognosis of myasthenia gravis in older people. ( Batocchi, AP; Di Schino, C; Evoli, A; Minisci, C; Tonali, P, 2000) |
| "Ocular myasthenia gravis is a subtype of myasthenia gravis that causes relatively mild disability, but may convert into severe generalised muscle weakness." | 1.30 | Ocular myasthenia gravis: response to long-term immunosuppressive treatment. ( Dichgans, J; Herzau, V; Melms, A; Schepelmann, K; Sigg, B; Sommer, N; Weller, M, 1997) |
| "Relapses are frequent after treatment withdrawal." | 1.30 | [Treatment of myasthenia: role of corticoids and immunosuppressive agents]. ( Gajdos, P, 1999) |
| "We carried out lymphocytapheresis (LCP) in combination with the administration of immunosuppressive drugs in patients with myasthenia gravis (MG), who were resistant to conventional immunosuppressive therapy, and examined its efficacy and effects on peripheral blood lymphocyte subsets." | 1.29 | Lymphocytapheresis in combination with immunosuppressive drugs for refractory myasthenia gravis: two-color flow cytometric analysis of changes in peripheral blood lymphocyte subsets. ( Furutama, D; Makino, S; Nakajima, H; Ohsawa, N; Shinoda, K, 1995) |
| "Prednisone was used in 17 cases, high dosage of methylprednisolone in 8 (in one case twice), azathioprine in 11 and cyclophosphamide in 10." | 1.28 | Immunosuppressive treatment for juvenile myasthenia gravis. ( Badurska, B; Ryniewicz, B; Strugalska, H, 1992) |
| "Thymoma was more common in the older population; these patients did no worse than the population as a whole." | 1.28 | The relationship of age to outcome in myasthenia gravis. ( Ansher, M; Donaldson, DH; Horan, S; Ringel, SP; Rutherford, RB, 1990) |
| "A patient developed respiratory failure after surgical removal of a recurrent thymoma, which necessitated removal of part of the diaphragm." | 1.28 | Unsuspected myasthenia gravis presenting as respiratory failure. ( Green, M; Laroche, C; Mier, A, 1990) |
| " In patients without clinical remission immunosuppressive drugs were prescribed in different schedule; the greater percentage of pharmacological remissions with less adverse effects was obtained with administration of prednisone 50-75 mg/die initially, than gradually reduced to smaller dosage in alternate day, associated to azathioprine." | 1.27 | Myasthenia gravis treatment: twelve years experience on 110 patients. ( Jann, S; Premoselli, S; Scarlato, G; Valli, G, 1987) |
| "20 patients with myasthenia gravis (MG), refractory to anticholinesterase and steroid therapy, underwent plasma exchange therapy combined with immunosuppressive drugs and lymphocytapheresis." | 1.26 | Plasma exchange combined with cytotoxic drugs and lymphocytapheresis for myasthenia gravis. ( Cornelio, F; Forlani, G; Garelli, S; Pelucchetti, D; Valbonesi, M; Zerbi, D, 1982) |
| "A group of 16 patients with severe generalized myasthenia gravis (MG) (five with thymoma) that was resistant to anticholinesterases, thymectomy, and corticosteroids were treated by plasmapheresis." | 1.26 | Plasmapheresis in refractory generalized myasthenia gravis. ( Ambinder, EP; Bender, AN; Genkins, G; Goldberg, J; Kornfeld, P; Mittag, T; Papatestas, AE, 1981) |
| "Anti-acetylcholine receptor antibody titres have been monitored in the sera of 19 myasthenic patients treated with plasma exchange combined with a three month period of immunosuppressive therapy." | 1.26 | Anti-acetylcholine receptor antibody titres in the sera of myasthenia patients treated with plasma exchange combined with immunosuppressive therapy. ( Behan, PO; Carter, B; Harrison, R; Lunt, GG; Simpson, JA, 1980) |
| "Twenty-one patients with myasthenia gravis underwent a course of plasma exchange combined with immunosuppressive therapy." | 1.26 | Plasma-exchange combined with immunosuppressive therapy in myasthenia gravis. ( Allan, TL; Behan, PO; Burnett, AK; Haase, G; Shakir, RA; Simpson, JA, 1979) |
| "Azathioprine treatment has been given to 26 patients for periods up to 7 years." | 1.26 | Effects of some immunosuppressive procedures on myasthenia gravis. ( Bergström, K; Franksson, C; Hammarström, L; Lefvert, AK; Matell, G; Möller, E; Smith, E; von Reis, G, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 104 (42.98) | 18.7374 |
| 1990's | 40 (16.53) | 18.2507 |
| 2000's | 46 (19.01) | 29.6817 |
| 2010's | 41 (16.94) | 24.3611 |
| 2020's | 11 (4.55) | 2.80 |
| Authors | Studies |
|---|---|
| Xu, Y | 1 |
| Chen, M | 1 |
| Xie, L | 1 |
| Zhang, X | 1 |
| Wang, Y | 1 |
| Gu, X | 1 |
| Rodolico, C | 1 |
| Bonanno, C | 1 |
| Brizzi, T | 1 |
| Nicocia, G | 1 |
| Trimarchi, G | 1 |
| Lupica, A | 1 |
| Pugliese, A | 1 |
| Musumeci, O | 1 |
| Toscano, A | 2 |
| Afshari, FT | 1 |
| Parida, A | 1 |
| Debenham, P | 1 |
| Solanki, GA | 1 |
| Hsu, WY | 1 |
| Lin, PC | 1 |
| Liu, YC | 1 |
| Lin, LC | 1 |
| Ingelfinger, F | 1 |
| Sparano, C | 1 |
| Bamert, D | 1 |
| Reyes-Leiva, D | 1 |
| Sethi, A | 1 |
| Rindlisbacher, L | 1 |
| Zwicky, P | 1 |
| Kreutmair, S | 1 |
| Widmer, CC | 1 |
| Mundt, S | 1 |
| Cortés-Vicente, E | 1 |
| Tugues, S | 1 |
| Becher, B | 1 |
| Schreiner, B | 1 |
| Prado, MB | 1 |
| Adiao, KJB | 1 |
| Cai, XJ | 1 |
| Li, ZW | 1 |
| Xi, JY | 1 |
| Song, HZ | 1 |
| Liu, J | 1 |
| Zhu, WH | 1 |
| Guo, Y | 1 |
| Jiao, Z | 1 |
| Cutter, G | 1 |
| Xin, H | 1 |
| Aban, I | 1 |
| Burns, TM | 1 |
| Allman, PH | 1 |
| Farzaneh-Far, R | 1 |
| Duda, PW | 1 |
| Kaminski, HJ | 2 |
| Lorenzoni, PJ | 1 |
| Kay, CSK | 1 |
| Zanlorenzi, MF | 1 |
| Ducci, RD | 1 |
| Werneck, LC | 2 |
| Scola, RH | 1 |
| Zhang, C | 1 |
| Bu, B | 1 |
| Yang, H | 1 |
| Wang, L | 1 |
| Liu, W | 1 |
| Duan, RS | 1 |
| Zhang, M | 1 |
| Zeng, P | 1 |
| Du, C | 1 |
| Yang, L | 1 |
| Shi, FD | 1 |
| Sharshar, T | 2 |
| Porcher, R | 1 |
| Demeret, S | 1 |
| Tranchant, C | 2 |
| Gueguen, A | 1 |
| Eymard, B | 1 |
| Nadaj-Pakleza, A | 1 |
| Spinazzi, M | 1 |
| Grimaldi, L | 1 |
| Birnbaum, S | 1 |
| Friedman, D | 1 |
| Clair, B | 1 |
| Nath, UK | 1 |
| Bhattacharyya, D | 1 |
| Chattopadhya, D | 1 |
| Dhingra, G | 1 |
| Azad, S | 1 |
| Mohanty, A | 1 |
| Zhang, Z | 1 |
| Wang, M | 1 |
| Xu, L | 1 |
| Jiang, B | 1 |
| Jin, T | 1 |
| Shi, T | 1 |
| Xu, B | 1 |
| Dube, M | 1 |
| Sodani, A | 1 |
| Chouksey, D | 1 |
| Europa, TA | 1 |
| Nel, M | 1 |
| Heckmann, JM | 5 |
| Harley, B | 1 |
| Shivapathasundram, G | 1 |
| Astradsson, A | 1 |
| Muthurajah, V | 1 |
| Wickremesekera, A | 1 |
| Liang, SE | 1 |
| Cohen, JM | 1 |
| Meehan, SA | 1 |
| Rothman, LR | 1 |
| Liebman, TN | 1 |
| Jordan, B | 1 |
| Zierz, S | 3 |
| Weber, T | 1 |
| Jordan, K | 1 |
| Abraham, A | 1 |
| Lovblom, LE | 1 |
| Bril, V | 1 |
| Pedersen, EG | 2 |
| Pottegård, A | 2 |
| Hallas, J | 2 |
| Friis, S | 2 |
| Hansen, K | 2 |
| Jensen, PE | 2 |
| Gaist, D | 2 |
| Varela, M | 1 |
| García-Camba, P | 1 |
| Gutiérrez Mosquera, B | 1 |
| García Rosas, S | 1 |
| Lorda, I | 1 |
| Auret, J | 1 |
| Abrahams, A | 1 |
| Prince, S | 1 |
| Frederiksen, JK | 1 |
| Ross, CW | 1 |
| Termsarasab, P | 1 |
| Katirji, B | 1 |
| Chertoff, J | 1 |
| Alam, S | 1 |
| Black, M | 1 |
| Elgendy, IY | 1 |
| Benjamin, B | 1 |
| Zaltzman, R | 1 |
| Shpitz, B | 1 |
| Gordon, CR | 1 |
| Avital, S | 1 |
| Gao, F | 1 |
| Zhao, X | 1 |
| Zhang, J | 1 |
| Cui, X | 1 |
| Zhang, Y | 2 |
| Li, Q | 1 |
| Liu, P | 1 |
| Fang, H | 1 |
| Du, Y | 1 |
| Zhang, Q | 1 |
| Yang, J | 1 |
| Mavrogeni, S | 1 |
| Ntoskas, T | 1 |
| Gialafos, E | 1 |
| Karabela, G | 1 |
| Krommida, M | 1 |
| Gatzonis, S | 1 |
| Siatouni, A | 1 |
| Kolovou, G | 1 |
| Zouvelou, V | 1 |
| Stamboulis, E | 1 |
| McGurgan, IJ | 1 |
| McGuigan, C | 1 |
| Gupta, A | 1 |
| Goyal, V | 1 |
| Srivastava, AK | 1 |
| Shukla, G | 1 |
| Behari, M | 1 |
| Rae, W | 1 |
| Burke, G | 1 |
| Pinto, A | 1 |
| Kroczka, S | 2 |
| Stasiak, K | 1 |
| Kaciński, M | 2 |
| Modrego, PJ | 1 |
| Arribas, J | 1 |
| Jack, KL | 1 |
| Koopman, WJ | 1 |
| Hulley, D | 1 |
| Nicolle, MW | 1 |
| Colleoni, L | 1 |
| Galbardi, B | 1 |
| Barzago, C | 1 |
| Bonanno, S | 1 |
| Franzi, S | 1 |
| Frangiamore, R | 1 |
| Camera, G | 1 |
| Foti, M | 1 |
| Biancolini, D | 1 |
| Canioni, E | 1 |
| Maggi, L | 1 |
| Antozzi, C | 3 |
| Mantegazza, R | 4 |
| Bernasconi, P | 1 |
| Kapetis, D | 1 |
| Jagathesan, T | 1 |
| O'Brien, MD | 1 |
| El-Azhary, RA | 1 |
| Brunner, KL | 1 |
| Gibson, LE | 1 |
| Kerkeni, S | 1 |
| Marotte, H | 1 |
| Miossec, P | 1 |
| Antonio-Santos, AA | 1 |
| Eggenberger, ER | 1 |
| Gedizlioglu, M | 1 |
| Coban, P | 1 |
| Ce, P | 1 |
| Sivasli, IE | 1 |
| Steczkowska, M | 1 |
| Nowak, A | 1 |
| Schoser, B | 1 |
| Jacob, S | 1 |
| Hilton-Jones, D | 2 |
| Müller-Felber, W | 2 |
| Kubisch, C | 1 |
| Claus, D | 1 |
| Goebel, HH | 2 |
| Vita, G | 1 |
| Vincent, A | 4 |
| Van den Bergh, P | 1 |
| Fleury, MC | 1 |
| Rózsa, C | 2 |
| Mikor, A | 1 |
| Kasa, K | 1 |
| Illes, Z | 1 |
| Komoly, S | 2 |
| Angelucci, E | 1 |
| Cesarini, M | 1 |
| Vernia, P | 1 |
| Appenzeller, S | 1 |
| Veilleux, M | 1 |
| Clarke, A | 1 |
| Hanisch, F | 2 |
| Wendt, M | 1 |
| Dunand, M | 1 |
| Botez, SA | 1 |
| Borruat, FX | 1 |
| Roux-Lombard, P | 1 |
| Spertini, F | 1 |
| Kuntzer, T | 1 |
| Dillon, P | 1 |
| Thomas, N | 1 |
| Sharpless, N | 1 |
| Collichio, F | 1 |
| Allen, JA | 1 |
| Scala, S | 1 |
| Jones, HR | 1 |
| Soni, CR | 1 |
| Kumar, G | 1 |
| Bollu, PC | 1 |
| Sahota, P | 1 |
| Litofsky, NS | 1 |
| Finsterer, J | 2 |
| Frank, M | 1 |
| Krexner, E | 1 |
| Hartert, M | 1 |
| Ströbel, P | 1 |
| Dahm, M | 1 |
| Nix, W | 1 |
| Marx, A | 1 |
| Vahl, CF | 1 |
| Heredia, F | 1 |
| Sousa, J | 1 |
| Magalhães, S | 1 |
| Pinheiro, R | 1 |
| Rigamonti, A | 1 |
| Lauria, G | 1 |
| Piamarta, F | 1 |
| Fiumani, A | 1 |
| Agostoni, E | 1 |
| Rawoot, A | 2 |
| Bateman, K | 1 |
| Renison, R | 1 |
| Badri, M | 1 |
| Pál, Z | 1 |
| Boczán, J | 1 |
| Bereznai, B | 1 |
| Lovas, G | 2 |
| Molnár, MJ | 1 |
| Höflich, S | 1 |
| Hurtado-Garcia, R | 2 |
| Escribano-Stablé, JC | 1 |
| Pascual, Jc | 1 |
| Devesa, P | 1 |
| Matarredona, J | 1 |
| Braun, SA | 1 |
| Helbig, D | 1 |
| Frank, J | 1 |
| Hanneken, S | 1 |
| Yoshikawa, H | 1 |
| Haas, M | 1 |
| Mayr, N | 2 |
| Zeitlhofer, J | 3 |
| Goldammer, A | 1 |
| Derfler, K | 1 |
| Raksadawan, N | 1 |
| Kankirawatana, P | 1 |
| Balankura, K | 1 |
| Prateepratana, P | 1 |
| Sangruchi, T | 1 |
| Atchaneeyasakul, LO | 1 |
| Barthelmes, L | 1 |
| Thomas, KJ | 1 |
| Seale, JR | 1 |
| Gogovska, L | 1 |
| Ljapcev, R | 1 |
| Polenakovic, M | 1 |
| Stojkovski, L | 1 |
| Popovska, M | 1 |
| Grcevska, L | 1 |
| Evoli, A | 5 |
| Tonali, PA | 1 |
| Padua, L | 1 |
| Monaco, ML | 1 |
| Scuderi, F | 1 |
| Batocchi, AP | 3 |
| Marino, M | 1 |
| Bartoccioni, E | 1 |
| Levin, N | 2 |
| Karussis, D | 2 |
| Abramsky, O | 4 |
| Taylor, I | 1 |
| Romi, F | 2 |
| Gilhus, NE | 3 |
| Varhaug, JE | 1 |
| Myking, A | 1 |
| Aarli, JA | 3 |
| Grando, SA | 1 |
| Richaud-Patin, Y | 1 |
| Vega-Boada, F | 1 |
| Vidaller, A | 1 |
| Llorente, L | 1 |
| Schneider-Gold, C | 1 |
| Gajdos, P | 2 |
| Toyka, KV | 5 |
| Hohlfeld, RR | 1 |
| Sieb, JP | 1 |
| Tireli, H | 1 |
| Karlikaya, G | 1 |
| Tutkavul, K | 1 |
| Akpinar, A | 1 |
| Okay, T | 1 |
| Lossos, A | 1 |
| Siegal, T | 1 |
| Argov, Z | 1 |
| Ben Hur, T | 1 |
| Finelli, PF | 1 |
| Fattorossi, A | 1 |
| Battaglia, A | 1 |
| Buzzonetti, A | 1 |
| Ciaraffa, F | 1 |
| Scambia, G | 1 |
| Lin, PT | 1 |
| Martin, BA | 1 |
| Weinacker, AB | 1 |
| So, YT | 1 |
| Bau, V | 1 |
| Hain, B | 1 |
| Skeie, GO | 1 |
| Apostolski, S | 1 |
| Hart, IK | 3 |
| Harms, L | 1 |
| Melms, A | 5 |
| Verschuuren, J | 1 |
| Horge, HW | 1 |
| Ashraf, VV | 1 |
| Taly, AB | 1 |
| Veerendrakumar, M | 1 |
| Rao, S | 1 |
| Nguyen, S | 1 |
| Morel, V | 1 |
| Le Garff-Tavernier, M | 1 |
| Bolgert, F | 1 |
| Leblond, V | 1 |
| Debré, P | 1 |
| Vieillard, V | 1 |
| Fornadi, L | 1 |
| Szabo, G | 1 |
| Little, F | 1 |
| Benatar, M | 1 |
| Sathasivam, S | 1 |
| Kunze, K | 1 |
| Bateman, BG | 1 |
| Nunley, WC | 1 |
| Kitchin, JD | 1 |
| Milner-Brown, HS | 1 |
| Miller, RG | 1 |
| Fiacchino, F | 2 |
| Crenna, P | 1 |
| Sghirlanzoni, A | 4 |
| Peluchetti, D | 4 |
| Allegranza, A | 1 |
| Patzold, U | 2 |
| Kalies, I | 1 |
| Haas, J | 2 |
| Ginda, EM | 1 |
| Marconi, G | 1 |
| Bobbi, S | 1 |
| Pizzi, A | 1 |
| Sbrilli, C | 1 |
| Taiuti, R | 1 |
| Ronchi, O | 1 |
| Avanzi, G | 1 |
| Lombardo, R | 1 |
| Franco, C | 1 |
| Biani, D | 1 |
| Schumm, F | 2 |
| Fateh-Moghadam, A | 2 |
| Dichgans, J | 3 |
| Watts, GF | 1 |
| Corston, R | 1 |
| Brinkmann, A | 1 |
| Witte, AS | 2 |
| Cornblath, DR | 2 |
| Parry, GJ | 1 |
| Lisak, RP | 2 |
| Schatz, NJ | 2 |
| Oosterhuis, HJ | 4 |
| Limburg, PC | 1 |
| Hummel-Tappel, E | 1 |
| The, TH | 1 |
| Mertens, HG | 4 |
| Hertel, G | 3 |
| Reuther, P | 2 |
| Ricker, K | 3 |
| Dau, PC | 4 |
| Eppel, M | 1 |
| Streib, EW | 1 |
| Reinicke, H | 1 |
| Weber, FW | 1 |
| Hausamen, TU | 1 |
| Valbonesi, M | 1 |
| Garelli, S | 1 |
| Zerbi, D | 1 |
| Forlani, G | 1 |
| Cornelio, F | 4 |
| Pelucchetti, D | 1 |
| Fasshauer, K | 2 |
| Rath, I | 1 |
| Kornfeld, P | 2 |
| Ambinder, EP | 2 |
| Mittag, T | 1 |
| Bender, AN | 1 |
| Papatestas, AE | 2 |
| Goldberg, J | 1 |
| Genkins, G | 2 |
| Hawkey, CJ | 1 |
| Newsom-Davis, J | 6 |
| Fuchs, S | 4 |
| Bartfeld, D | 1 |
| Eshhar, Z | 1 |
| Feingold, C | 1 |
| Mochly-Rosen, D | 1 |
| Novick, D | 1 |
| Schwartz, M | 1 |
| Tarrab-Hazdai, R | 3 |
| Carter, B | 1 |
| Harrison, R | 1 |
| Lunt, GG | 1 |
| Behan, PO | 2 |
| Simpson, JA | 2 |
| Ito, N | 1 |
| Malcherek, G | 1 |
| Gern, U | 1 |
| Sommer, N | 3 |
| Weissert, R | 1 |
| Wiethölter, H | 1 |
| Bühring, HJ | 1 |
| Chatté, G | 1 |
| Langevin, B | 1 |
| Cosi, V | 2 |
| Lombardi, M | 2 |
| Erbetta, A | 1 |
| Piccolo, G | 2 |
| Burke, ME | 1 |
| Wilensky, R | 1 |
| Dwyer, B | 1 |
| Mayer, RF | 1 |
| Confalonieri, P | 1 |
| Berta, E | 1 |
| Furutama, D | 1 |
| Nakajima, H | 1 |
| Shinoda, K | 1 |
| Makino, S | 1 |
| Ohsawa, N | 1 |
| Glennerster, A | 1 |
| Palace, J | 2 |
| Warburton, D | 1 |
| Oxbury, S | 1 |
| Konishi, T | 1 |
| Miki, S | 1 |
| Yoshida, A | 1 |
| Tei, M | 1 |
| Sigg, B | 1 |
| Weller, M | 2 |
| Schepelmann, K | 1 |
| Herzau, V | 1 |
| Tonali, P | 2 |
| Beekman, R | 1 |
| Kuks, JB | 2 |
| Bromberg, MB | 1 |
| Wald, JJ | 1 |
| Forshew, DA | 1 |
| Feldman, EL | 1 |
| Albers, JW | 1 |
| Tumani, H | 1 |
| George, A | 1 |
| Nau, R | 1 |
| Lindner, A | 1 |
| Schalke, B | 1 |
| Schmidt, S | 1 |
| Padberg, F | 1 |
| Lecky, B | 1 |
| Heitmiller, RF | 1 |
| Eisensehr, I | 1 |
| Büttner, U | 1 |
| Witt, TN | 1 |
| von Appen, K | 1 |
| Spuler, S | 1 |
| Ansevin, CF | 1 |
| Müller-Jenssen, A | 1 |
| Töpfer, M | 1 |
| Pongratz, DE | 1 |
| Herrlinger, U | 1 |
| Leavitt, JA | 1 |
| Takahashi, K | 1 |
| Inoue, Y | 1 |
| Matsuda, O | 1 |
| Takemura, T | 1 |
| Yoshimura, A | 1 |
| Minisci, C | 1 |
| Di Schino, C | 1 |
| Sempowski, G | 1 |
| Thomasch, J | 1 |
| Gooding, M | 1 |
| Hale, L | 1 |
| Edwards, L | 1 |
| Ciafaloni, E | 1 |
| Sanders, D | 1 |
| Massey, J | 1 |
| Douek, D | 1 |
| Koup, R | 1 |
| Haynes, B | 1 |
| Abt, PL | 1 |
| Patel, HJ | 1 |
| Marsh, A | 1 |
| Schwartz, SI | 1 |
| Tackenberg, B | 1 |
| Hemmer, B | 1 |
| Oertel, WH | 1 |
| LeePan, EB | 1 |
| Eastman, RW | 1 |
| Téllez-Zenteno, JF | 1 |
| Remes-Troche, JM | 1 |
| García-Ramos, G | 1 |
| Estañol, B | 1 |
| Garduño-Espinoza, J | 1 |
| Roberts, ME | 1 |
| Steiger, MJ | 1 |
| Pinching, AJ | 1 |
| Peters, DK | 1 |
| Wilson, SG | 1 |
| Ward, CD | 1 |
| Shakir, RA | 1 |
| Burnett, AK | 1 |
| Allan, TL | 1 |
| Haase, G | 1 |
| Bergström, K | 4 |
| Franksson, C | 3 |
| Matell, G | 7 |
| Nilsson, BY | 1 |
| Persson, A | 1 |
| von Reis, G | 4 |
| Stensman, R | 1 |
| Hammarström, L | 1 |
| Lefvert, AK | 3 |
| Möller, E | 1 |
| Smith, E | 1 |
| Birnberger, KL | 1 |
| Struppler, A | 2 |
| Jerusalem, F | 2 |
| Osterman, PO | 2 |
| Pirskanen, R | 1 |
| Lobzin, VS | 1 |
| Golovkin, VI | 1 |
| Chalov, IuV | 1 |
| Johns, TR | 1 |
| Howard, FM | 1 |
| Grgić, Z | 1 |
| Janzen, RW | 1 |
| Lachenmayer, L | 1 |
| Fischer, K | 1 |
| Truniger, B | 1 |
| Jusić, A | 1 |
| Zagar, M | 1 |
| Wiebecke, D | 1 |
| Böske, A | 1 |
| Inada, M | 1 |
| Nishikawa, M | 1 |
| Oishi, M | 1 |
| Kurata, S | 1 |
| Ogawa, H | 1 |
| Sakurami, T | 1 |
| Kono, T | 1 |
| Imura, H | 1 |
| Arimori, S | 2 |
| Nakata, Y | 1 |
| Tada, S | 1 |
| Kobashi, H | 1 |
| Koriyama, K | 1 |
| Ichikawa, Y | 1 |
| Mitsuhashi, A | 1 |
| Iwasaki, I | 1 |
| Hiraki, K | 1 |
| Klingler, D | 1 |
| Necek, S | 1 |
| Brücke, P | 1 |
| Meier-Ewert, KH | 1 |
| Lindstrom, JM | 2 |
| Cassel, CK | 1 |
| Denys, EH | 1 |
| Shev, EE | 1 |
| Spitler, LE | 1 |
| Aharonov, A | 1 |
| Vallet, B | 1 |
| Fourrier, F | 1 |
| Hurtevent, JF | 1 |
| Parent, M | 1 |
| Chopin, C | 1 |
| Badurska, B | 1 |
| Ryniewicz, B | 1 |
| Strugalska, H | 1 |
| Klimova, TT | 1 |
| Sanadze, AG | 1 |
| Skoromets, AA | 1 |
| Khliustova, OV | 1 |
| Djojoatmodjo, S | 1 |
| Moreira, PR | 1 |
| Müller, KM | 1 |
| Nykyri, E | 1 |
| Andersson, LC | 1 |
| Paolisso, G | 1 |
| Varricchio, M | 1 |
| Donofrio, F | 1 |
| Neretin, VIa | 1 |
| Odinokova, VA | 1 |
| Kir'iakov, VA | 1 |
| Sapfirova, VA | 1 |
| Fonseca, V | 2 |
| Havard, CW | 2 |
| Zimmermann, CW | 1 |
| Lingenfelser, T | 1 |
| Jakober, B | 1 |
| Kumagai, M | 1 |
| Kondou, T | 1 |
| Handa, M | 1 |
| Shiraishi, Y | 1 |
| Fujimura, S | 1 |
| Nakata, T | 1 |
| Rahn, E | 1 |
| Bechthold, HG | 1 |
| Mathieson, PW | 1 |
| O'Neill, JH | 1 |
| Durrant, ST | 1 |
| Henderson, SJ | 1 |
| Green, PJ | 1 |
| Donaldson, DH | 1 |
| Ansher, M | 1 |
| Horan, S | 1 |
| Rutherford, RB | 1 |
| Ringel, SP | 2 |
| Nasca, TJ | 1 |
| Muder, RR | 1 |
| Thomas, DB | 1 |
| Schrecker, JC | 1 |
| Ruben, FL | 1 |
| Sandmann, MC | 1 |
| Gorz, AM | 1 |
| Gracia, CM | 1 |
| Batista, RJ | 1 |
| Seixas, RR | 1 |
| Bittencourt, PR | 1 |
| Mier, A | 1 |
| Laroche, C | 1 |
| Green, M | 1 |
| Smith, N | 1 |
| Boughton, BJ | 1 |
| Ivanov, IP | 1 |
| Kolomenskaia, EA | 1 |
| Iakovleva, AN | 1 |
| Sabouraud, O | 1 |
| Schalke, BC | 1 |
| Kirchner, T | 1 |
| Wegener, S | 1 |
| Müller-Hermelink, HK | 1 |
| Fischer, JE | 1 |
| Pan, CH | 1 |
| Chiang, CY | 1 |
| Chen, SS | 1 |
| Sato, T | 1 |
| Ishigaki, Y | 1 |
| Komiya, T | 1 |
| Tsuda, H | 1 |
| Henze, T | 2 |
| Toifl, K | 1 |
| Vass, B | 1 |
| Michels, M | 2 |
| Hohlfeld, R | 3 |
| Hartung, HP | 1 |
| Heininger, K | 3 |
| Besinger, UA | 2 |
| Nyberg-Hansen, R | 1 |
| Gjerstad, L | 1 |
| Besinger, U | 1 |
| Valli, G | 1 |
| Jann, S | 1 |
| Premoselli, S | 1 |
| Scarlato, G | 1 |
| Collarile, C | 1 |
| Fennell, DF | 1 |
| Scherpbier, HJ | 1 |
| Kern, RZ | 1 |
| Stewart, JD | 1 |
| Maida, EM | 1 |
| Mamoli, B | 1 |
| De Assis, JL | 1 |
| Marchiori, PE | 1 |
| Scaff, M | 1 |
| Zambon, AA | 1 |
| Gerhold, B | 1 |
| Matta, R | 1 |
| Bender, A | 1 |
| Gross, H | 1 |
| Herrmann, C | 1 |
| Keesey, JC | 1 |
| Mulder, DG | 1 |
| Niakan, E | 1 |
| Harati, Y | 1 |
| Rolak, LA | 1 |
| Huber, A | 1 |
| Fornasari, PM | 1 |
| Riva, G | 1 |
| Clarke, SW | 1 |
| Kendall, MJ | 1 |
| MacGregor, GA | 1 |
| Pirofsky, B | 1 |
| Reid, RR | 1 |
| Ramirez-Mateos, JC | 1 |
| Bardana, EJ | 1 |
| August, A | 1 |
| Balzereit, F | 1 |
| Leipert, M | 1 |
| Delwaide, PJ | 1 |
| Salmon, J | 1 |
| Van Cauwenberge, H | 1 |
| Ricken, D | 1 |
| Cendrowski, W | 1 |
| Riekkinen, PJ | 1 |
| Rinne, UK | 1 |
| Skinner, MD | 1 |
| Schwartz, RS | 1 |
| Haas, DC | 1 |
| Arnason, BG | 1 |
| Doll, R | 1 |
| Kinlen, L | 1 |
| Brendel, W | 1 |
| Seifert, J | 1 |
| Lob, G | 1 |
| Böttcher, D | 1 |
| Maas, D | 1 |
| Wendt, F | 1 |
| Schubothe, H | 1 |
| Rowland, LP | 1 |
| Hokkanen, E | 1 |
| Eckmann, L | 1 |
| Namba, T | 1 |
| Grob, D | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Comparison of Two Tapering Strategies of Prednisone in Patients With Generalised Myasthenia Gravis Treated With Prednisone and Azathioprine: a Single-blind Randomised Controlled Multicenter Study[NCT00987116] | Phase 4 | 118 participants (Actual) | Interventional | 2009-06-30 | Completed | ||
| An Open Randomized Comparative Trial of Four Different Dressings for Cutaneous Coverage in Pemphigus and Pemphigoid[NCT02365675] | 12 participants (Anticipated) | Interventional | 2015-01-31 | Recruiting | |||
| Comparative Analysis of the Th17 Cellular Response in Active and Inactive Pemphigus Vulgaris Patients[NCT04096222] | 42 participants (Anticipated) | Observational | 2021-06-29 | Recruiting | |||
| Phase 1-2 Pilot Study of Rituximab (Rituxan) in Refractory Myasthenia Gravis.[NCT00619671] | Phase 1/Phase 2 | 10 participants (Anticipated) | Interventional | 2004-04-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
28 reviews available for azathioprine and Anti-MuSK Myasthenia Gravis
| Article | Year |
|---|---|
Myasthenia gravis complicating the surgical management of achondroplasia: a case-based update.
Topics: Achondroplasia; Anesthetics; Azathioprine; Child; Constriction, Pathologic; COVID-19; Female; Humans | 2022 |
Methotrexate in generalized myasthenia gravis: a systematic review.
Topics: Azathioprine; Drug-Related Side Effects and Adverse Reactions; Humans; Immunosuppressive Agents; Met | 2023 |
Myasthenia gravis and specific immunotherapy: monoclonal antibodies.
Topics: Antibodies, Monoclonal; Azathioprine; Cholinesterase Inhibitors; Humans; Immunosuppressive Agents; I | 2019 |
Cancer occurrence following azathioprine treatment in myasthenia gravis patients: A systematic review and meta-analysis.
Topics: Azathioprine; Humans; Immunosuppressive Agents; Myasthenia Gravis; Neoplasms; Prospective Studies | 2021 |
Azathioprine-induced hepatitis and cholestasis occurring 1 year after treatment.
Topics: Administration, Oral; Azathioprine; Biopsy, Needle; Chemical and Drug Induced Liver Injury; Cholesta | 2014 |
Medical treatment options for ocular myasthenia gravis.
Topics: Azathioprine; Glucocorticoids; Humans; Immunologic Factors; Immunosuppressive Agents; Myasthenia Gra | 2008 |
[Myasthenia gravis].
Topics: Adrenal Cortex Hormones; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Azat | 2008 |
Corticosteroids for myasthenia gravis.
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Azathioprine; Glucocorticoids; Humans; Immunog | 2005 |
Myasthenia gravis: emerging new therapy options.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Humans; Immunoglobulin | 2005 |
Evidence report: the medical treatment of ocular myasthenia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Azathioprine; Cholinesterase Inhibitors; Evide | 2007 |
Immunosuppressive agents for myasthenia gravis.
Topics: Adrenal Cortex Hormones; Azathioprine; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Hu | 2007 |
Myasthenia gravis and pregnancy.
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Cholinesterase Inhibitors; Combined Modality Therapy; | 1993 |
A practical guide to the recognition and management of myasthenia gravis.
Topics: Adrenal Cortex Hormones; Azathioprine; Cholinesterase Inhibitors; Cyclosporine; Diagnosis, Different | 1996 |
Myasthenia gravis: clinical features, pathogenesis, evaluation, and medical management.
Topics: Adrenal Cortex Hormones; Autoimmune Diseases; Azathioprine; Cholinesterase Inhibitors; Humans; Immun | 1999 |
[A case of myasthenia gravis, who developed minimal change nephrotic syndrome during immunosuppressive therapy after thymectomy].
Topics: Azathioprine; Female; Humans; Immunosuppressive Agents; Middle Aged; Myasthenia Gravis; Nephrosis, L | 2000 |
Immunosuppressive treatment of ocular myasthenia gravis.
Topics: Adrenal Cortex Hormones; Azathioprine; Cholinesterase Inhibitors; Eye Diseases; Immunosuppressive Ag | 2001 |
Immunochemical analysis of acetylcholine receptor and its relevance to specific treatment of experimental autoimmune myasthenia gravis.
Topics: Acetylcholine; Animals; Antibodies; Autoimmune Diseases; Azathioprine; Binding Sites; Binding, Compe | 1979 |
[Myasthenia gravis and visceral lupus erythematosus].
Topics: Acetylcholine; Adult; Antibodies, Antinuclear; Antigen-Antibody Complex; Azathioprine; Cell Membrane | 1979 |
[Myasthenia gravis. New results on etiology, diagnosis and therapy].
Topics: Adrenal Cortex Hormones; Animals; Autoantibodies; Azathioprine; Binding Sites; Bungarotoxins; Electr | 1977 |
Azathioprine in myasthenia gravis: observations in 41 patients and a review of literature.
Topics: Adult; Autoantibodies; Azathioprine; Female; Follow-Up Studies; Humans; Male; Myasthenia Gravis; Rec | 1991 |
[Immunosuppressive therapy of various autoimmune diseases of the nervous system].
Topics: Autoimmune Diseases; Azathioprine; Cyclophosphamide; Drug Evaluation; Humans; Multiple Sclerosis; My | 1990 |
Current treatment of myasthenia gravis.
Topics: Adrenal Cortex Hormones; Azathioprine; Cholinesterase Inhibitors; Humans; Myasthenia Gravis; Plasma | 1990 |
Thymolipoma in patients with myasthenia gravis: report of two cases and review.
Topics: Azathioprine; Female; Humans; Lipoma; Middle Aged; Myasthenia Gravis; Prednisolone; Thymus Neoplasms | 1988 |
Immunopharmacological treatment in myasthenia gravis.
Topics: Adrenal Cortex Hormones; Animals; Autoantibodies; Autoimmune Diseases; Azathioprine; Combined Modali | 1988 |
Myasthenia gravis--current concepts.
Topics: Acetylcholine; Adrenal Cortex Hormones; Adult; Animals; Autoantibodies; Autoimmune Diseases; Azathio | 1985 |
[Immunosuppressive treatment in neurological disorders].
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Animals; Antilymphocyte Serum; Azathioprine; C | 1973 |
Immunosuppressive therapy in neurological diseases.
Topics: Adrenocorticotropic Hormone; Azathioprine; Central Nervous System Diseases; Cyclophosphamide; Cytara | 1974 |
Immunosuppressive therapy. 2.
Topics: Abnormalities, Drug-Induced; Adrenal Cortex Hormones; Adult; Azathioprine; Child; Chlorambucil; Clin | 1972 |
13 trials available for azathioprine and Anti-MuSK Myasthenia Gravis
| Article | Year |
|---|---|
Comparison of Corticosteroid Tapering Regimens in Myasthenia Gravis: A Randomized Clinical Trial.
Topics: Adrenal Cortex Hormones; Adult; Aged; Azathioprine; Drug Administration Schedule; Female; Glucocorti | 2021 |
A single-blinded trial of methotrexate versus azathioprine as steroid-sparing agents in generalized myasthenia gravis.
Topics: Adult; Azathioprine; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Myas | 2011 |
[Recent clinical trials on treatment of myasthenia gravis].
Topics: Azathioprine; Humans; Myasthenia Gravis; Mycophenolic Acid; Tacrolimus | 2012 |
Long-term treatment of myasthenia gravis with immunoadsorption.
Topics: Adult; Aged; Autoantibodies; Azathioprine; Female; Humans; Immunosorbent Techniques; Immunosuppressi | 2002 |
New approaches to the treatment of pemphigus.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Azathioprine; Cholinesterase Inhibitors; Dr | 2004 |
Multidrug resistance-1 (MDR-1) in autoimmune disorders IV. P-glycoprotein overfunction in lymphocytes from myasthenia gravis patients.
Topics: Adolescent; Adult; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azathioprine; Daunorubic | 2004 |
Seronegative myasthenia gravis: disease severity and prognosis.
Topics: Antibodies; Azathioprine; Case-Control Studies; Female; Humans; Immunosuppressive Agents; Incidence; | 2005 |
A randomised clinical trial comparing prednisone and azathioprine in myasthenia gravis. Results of the second interim analysis. Myasthenia Gravis Clinical Study Group.
Topics: Adult; Azathioprine; Female; Humans; Male; Middle Aged; Myasthenia Gravis; Prednisone; Treatment Fai | 1993 |
Randomized trial of azathioprine or prednisone for initial immunosuppressive treatment of myasthenia gravis.
Topics: Adult; Aged; Azathioprine; Cross-Over Studies; Female; Humans; Immunosuppressive Agents; Male; Middl | 1997 |
A randomized double-blind trial of prednisolone alone or with azathioprine in myasthenia gravis. Myasthenia Gravis Study Group.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies; Azathioprine; Double-Blind Method; Drug Ther | 1998 |
[Fluocortolon, azathioprine and cyclophosphamide in the therapy of myasthenia gravis].
Topics: Adolescent; Adult; Azathioprine; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combinati | 1979 |
Azathioprine as a single drug or in combination with steroids in the treatment of myasthenia gravis.
Topics: Adult; Azathioprine; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Immunosupp | 1988 |
Immunosuppressive therapy. 2.
Topics: Abnormalities, Drug-Induced; Adrenal Cortex Hormones; Adult; Azathioprine; Child; Chlorambucil; Clin | 1972 |
202 other studies available for azathioprine and Anti-MuSK Myasthenia Gravis
| Article | Year |
|---|---|
Cytomegalovirus-Associated Nephrotic Syndrome in a Patient with Myasthenia Gravis Treated with Azathioprine: A Case Report.
Topics: Azathioprine; Cytomegalovirus; Cytomegalovirus Infections; Humans; Myasthenia Gravis; Nephrotic Synd | 2021 |
Methotrexate as a Steroid-Sparing Agent in Myasthenia Gravis: A Preliminary Retrospective Study.
Topics: Azathioprine; Humans; Immunosuppressive Agents; Methotrexate; Myasthenia Gravis; Prednisone; Retrosp | 2021 |
Alopecia and colon ulcers following azathioprine use in a patient with myasthenia gravis: A case report.
Topics: Adolescent; Alopecia; Azathioprine; Colonic Diseases; Diarrhea; Female; Humans; Myasthenia Gravis; P | 2022 |
Azathioprine therapy induces selective NK cell depletion and IFN-γ deficiency predisposing to herpesvirus reactivation.
Topics: Azathioprine; Herpesviridae; Humans; Interferon-gamma; Killer Cells, Natural; Myasthenia Gravis | 2023 |
Cross-sectional analysis of the Myasthenia Gravis Patient Registry: Disability and treatment.
Topics: Activities of Daily Living; Adrenal Cortex Hormones; Adult; Aged; Azathioprine; Cholinesterase Inhib | 2019 |
Myasthenia gravis and azathioprine treatment: Adverse events related to thiopurine S-methyl-transferase (TPMT) polymorphisms.
Topics: Azathioprine; Brazil; Genotype; Humans; Methyltransferases; Myasthenia Gravis; Transferases | 2020 |
Immunotherapy choice and maintenance for generalized myasthenia gravis in China.
Topics: Adult; Aged; Azathioprine; China; Clinical Decision-Making; Cohort Studies; Female; Humans; Immunolo | 2020 |
Visceral leishmaniasis masquerading as drug-induced pancytopenia in myasthenia gravis.
Topics: Azathioprine; Diagnosis, Differential; Humans; Immunosuppressive Agents; Leishmaniasis, Visceral; Ma | 2021 |
Outcome of Myasthenia gravis treated with high-dose prednisolone and azathioprine: A single centre ambispective study from India.
Topics: Adult; Aged; Azathioprine; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Myasthenia | 2017 |
Myasthenic ophthalmoparesis: Time To resolution after initiating immune therapies.
Topics: Adult; Azathioprine; Female; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunologic Fact | 2018 |
An unusual presentation of cerebellar lymphoma.
Topics: Adult; Azathioprine; Cerebellar Neoplasms; Epstein-Barr Virus Infections; Female; Humans; Immunocomp | 2018 |
A 68-Year-Old Man on Azathioprine With New Systemic Symptoms and Widespread Skin Eruption.
Topics: Aged; Azathioprine; Diagnosis, Differential; Drug Hypersensitivity Syndrome; Exanthema; Humans; Immu | 2019 |
Successful use of an immune checkpoint inhibitor in a patient with myasthenia gravis in remission.
Topics: Antineoplastic Agents, Immunological; Azathioprine; Central Nervous System Neoplasms; Cholinesterase | 2019 |
Baseline Decrement in Patients with Mild Myasthenia Gravis Predicts Immunomodulation Treatment.
Topics: Adult; Aged; Azathioprine; Electromyography; Female; Humans; Immunoglobulins, Intravenous; Immunosup | 2019 |
Use of azathioprine for non-thymoma myasthenia and risk of cancer: a nationwide case-control study in Denmark.
Topics: Aged; Aged, 80 and over; Azathioprine; Case-Control Studies; Denmark; Female; Humans; Male; Middle A | 2013 |
[Delayed development of multiple supernumerary teeth in a patient with juvenile myasthenia gravis treated with azathioprine].
Topics: Azathioprine; Child; Female; Humans; Immunosuppressive Agents; Myasthenia Gravis; Time Factors; Toot | 2014 |
Risk of non-melanoma skin cancer in myasthenia patients treated with azathioprine.
Topics: Azathioprine; Case-Control Studies; Community Health Planning; Confidence Intervals; Denmark; Female | 2014 |
The effects of prednisone and steroid-sparing agents on decay accelerating factor (CD55) expression: implications in myasthenia gravis.
Topics: Animals; Azathioprine; CD55 Antigens; Cell Line; Chlorocebus aethiops; COS Cells; Cyclosporine; Gluc | 2014 |
Cytomegalovirus-associated hemophagocytic lymphohistiocytosis in a patient with myasthenia gravis treated with azathioprine.
Topics: Azathioprine; Cytomegalovirus Infections; Female; Humans; Immunocompromised Host; Immunosuppressive | 2014 |
Brainstem lymphoma in a myasthenia gravis patient on azathioprine.
Topics: Aged, 80 and over; Azathioprine; Brain Stem Neoplasms; Disease Progression; Fatal Outcome; Humans; I | 2015 |
Presacral Mass Discovered during Pregnancy followed by Myasthenia Gravis.
Topics: Adult; Azathioprine; Castleman Disease; Cholinesterase Inhibitors; Female; Humans; Immunosuppressive | 2015 |
Clinical features of patients with Myasthenia gravis from the Henan province, China.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Age Distribution; Age of Onset; Aged; Aged, 80 and over; | 2016 |
Silent myocarditis in myasthenia gravis. Role of cardiovascular magnetic resonance imaging.
Topics: Adult; Azathioprine; Cardiac Imaging Techniques; Echocardiography; Female; Humans; Immunosuppressive | 2016 |
Nonmelanoma skin cancer risk awareness in azathioprine-treated myasthenia gravis patients.
Topics: Adult; Aged; Aged, 80 and over; Azathioprine; Counseling; Female; Humans; Immunosuppressive Agents; | 2015 |
Remission And relapse of myasthenia gravis on long-term azathioprine: An ambispective study.
Topics: Adult; Analysis of Variance; Azathioprine; Cohort Studies; Female; Humans; Immunosuppressive Agents; | 2016 |
A study of the utility of azathioprine metabolite testing in myasthenia gravis.
Topics: Adult; Aged; Aged, 80 and over; Azathioprine; Cell Count; Cohort Studies; Female; Guanine Nucleotide | 2016 |
[Neurophysiological parameters in myasthena gravis in children in diagnostic and therapeutic view].
Topics: Adolescent; Age of Onset; Azathioprine; Child; Combined Modality Therapy; Diagnosis, Differential; E | 2016 |
Spontaneous resolution of a mediastinal mass in a woman with myasthenia gravis.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Hormonal; Azathioprine; Cholinesterase Inhib | 2018 |
A Review of Azathioprine-Associated Hepatotoxicity and Myelosuppression in Myasthenia Gravis.
Topics: Adult; Aged; Aged, 80 and over; Azathioprine; Chemical and Drug Induced Liver Injury; Female; Humans | 2016 |
A novel ABCC6 haplotype is associated with azathioprine drug response in myasthenia gravis.
Topics: Adult; Aged; Azathioprine; Female; Genetic Association Studies; Haplotypes; Humans; Male; Middle Age | 2017 |
Myasthenia Gravis and Its Aeromedical Implications.
Topics: Adult; Aerospace Medicine; Aged; Aviation; Azathioprine; Certification; Cholinesterase Inhibitors; D | 2017 |
Sweet syndrome as a manifestation of azathioprine hypersensitivity.
Topics: Adult; Aged; Azathioprine; Colitis, Ulcerative; Crohn Disease; Drug Hypersensitivity; Humans; Immuno | 2008 |
Improvement with rituximab in a patient with both rheumatoid arthritis and myasthenia gravis.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Arthritis, Rhe | 2008 |
An unusual complication of immunosuppression in myasthenia gravis: progressive multifocal leukoencephalopathy.
Topics: Adrenal Cortex Hormones; Adult; Ataxia; Azathioprine; Brain; Cognition Disorders; Disease Progressio | 2009 |
[Diagnostics and treatment of myasthenia gravis in children].
Topics: Adolescent; Azathioprine; Child; Electrophysiology; Female; Humans; Male; Myasthenia Gravis; Plasmap | 2008 |
Immune-mediated rippling muscle disease with myasthenia gravis: a report of seven patients with long-term follow-up in two.
Topics: Adult; Aged; Autoantibodies; Azathioprine; Caveolae; Caveolin 3; Cholinesterase Inhibitors; Electrom | 2009 |
Long-term effects of combined immunosuppressive treatment on myasthenic crisis.
Topics: Adult; Aged; Azathioprine; Case-Control Studies; Chi-Square Distribution; Clinical Trials as Topic; | 2009 |
Successful resolution of pneumonia developed in a patient affected by Crohn's disease, rheumatoid arthritis, myasthenia gravis and recurrent uveitis during concomitant treatment with tumour necrosis factor alpha inhibitors and conventional immunosuppressi
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, R | 2010 |
Third cranial nerve palsy or pseudo 3rd nerve palsy of myasthenia gravis? A challenging diagnosis in systemic lupus erythematosus.
Topics: Adrenal Cortex Hormones; Aged; Azathioprine; Diagnosis, Differential; Diplopia; Female; Humans; Immu | 2009 |
Mycophenolate mofetil as second line immunosuppressant in Myasthenia gravis--a long-term prospective open-label study.
Topics: Adult; Aged; Azathioprine; Female; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Male | 2009 |
Unsatisfactory outcomes in myasthenia gravis: influence by care providers.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Azathioprine; Child; Cholinesterase Inhibitors; Clinical | 2010 |
Regression of advanced melanoma upon withdrawal of immunosuppression: case series and literature review.
Topics: Aged; Azathioprine; Head and Neck Neoplasms; Humans; Immunosuppression Therapy; Immunosuppressive Ag | 2010 |
Ocular myasthenia gravis in a senior population: diagnosis, therapy, and prognosis.
Topics: Age Factors; Age of Onset; Aged; Aged, 80 and over; Azathioprine; Chi-Square Distribution; Cyclospor | 2010 |
Salmonella brain abscess in a patient on chronic azathioprine therapy for myasthenia gravis: report of an unusual case and review of literature in the postantibiotic era.
Topics: Abscess; Anti-Infective Agents; Azathioprine; Brain; Ciprofloxacin; Drug Administration Schedule; Fe | 2010 |
Low-dose azathioprine effectively suppresses clinical and immunological manifestations of generalized myasthenia.
Topics: Aged; Azathioprine; Female; Humans; Immunosuppressive Agents; Myasthenia Gravis | 2010 |
A follicular dendritic cell sarcoma of the mediastinum with immature T cells and association with myasthenia gravis.
Topics: Adult; Azathioprine; Biomarkers, Tumor; Dendritic Cell Sarcoma, Follicular; Humans; Immunohistochemi | 2010 |
Therapy-related myelodysplastic syndrome with 17p deletion following long-term azathioprine treatment.
Topics: Adult; Azathioprine; Chromosome Deletion; Chromosomes, Human, Pair 17; Female; Humans; Myasthenia Gr | 2010 |
Thymoma-associated myasthenia gravis without acetylcholine receptor antibodies.
Topics: Action Potentials; Anti-Inflammatory Agents; Autoantibodies; Azathioprine; Electric Stimulation; Evo | 2011 |
[Therapy for anti-MuSK antibody positive myasthenia gravis].
Topics: Adult; Autoantibodies; Azathioprine; Female; Humans; Immunosuppressive Agents; Methotrexate; Myasthe | 2011 |
Long-term, low-dose immunosuppression for myasthenia does not affect collateral, asymptomatic sclerosing cholangitis.
Topics: Aged; Asymptomatic Diseases; Azathioprine; Cholangitis, Sclerosing; Female; Humans; Immunosuppressio | 2012 |
Neutrophilic dermatosis caused by azathioprine hypersensitivity.
Topics: Adult; Azathioprine; Drug Eruptions; Female; Hand Dermatoses; Humans; Immunosuppressive Agents; Myas | 2012 |
[Eruptive melanocytic nevi during azathioprine therapy in myasthenia gravis].
Topics: Azathioprine; Drug Eruptions; Humans; Immunosuppressive Agents; Male; Myasthenia Gravis; Nevus, Pigm | 2012 |
Childhood onset myasthenia gravis.
Topics: Adolescent; Age Distribution; Age of Onset; Azathioprine; Child; Child, Preschool; Combined Modality | 2002 |
Prostatic involvement of a testicular lymphoma in a patient with myasthenia gravis on long-term azathioprine.
Topics: Azathioprine; Fatal Outcome; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle | 2002 |
Plasmaexchange in the treatment of myasthenia gravis associated with thymoma.
Topics: Adult; Azathioprine; Cholinesterase Inhibitors; Cyclosporine; Female; Glucocorticoids; Humans; Immun | 2003 |
Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.
Topics: Adolescent; Adult; Age of Onset; Aged; Autoantibodies; Azathioprine; Case-Control Studies; Child; Cy | 2003 |
Parkinson's disease associated with myasthenia gravis. A report of 4 cases.
Topics: Aged; Azathioprine; Cholinesterase Inhibitors; Drug Therapy, Combination; Female; Humans; Immunosupp | 2003 |
Cavernous hemangioma. Reversible posterior leukoencephalopathy syndrome.
Topics: Adult; Azathioprine; Diabetes Mellitus, Type 1; Diffusion Magnetic Resonance Imaging; Female; Hemang | 2003 |
Disease severity and outcome in thymoma myasthenia gravis: a long-term observation study.
Topics: Adrenal Cortex Hormones; Adult; Age of Onset; Autoantibodies; Azathioprine; Combined Modality Therap | 2003 |
Myasthenia gravis: how to treat?
Topics: Adolescent; Adult; Age Factors; Aged; Azathioprine; Drug Therapy, Combination; Female; Glucocorticoi | 2004 |
Extrathymic malignancies in patients with myasthenia gravis.
Topics: Adult; Age Factors; Age of Onset; Aged; Autoimmune Diseases; Azathioprine; Disease Progression; Fema | 2005 |
Primary CNS lymphoma in myasthenic on long-term azathioprine.
Topics: Antigens, CD20; Antimetabolites, Antineoplastic; Azathioprine; Brain Neoplasms; Diagnosis, Different | 2005 |
Circulating and thymic CD4 CD25 T regulatory cells in myasthenia gravis: effect of immunosuppressive treatment.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Azathioprine; CD4-Positive T-Lymphocytes; Cross-Sectiona | 2005 |
High-dose cyclophosphamide in refractory myasthenia gravis with MuSK antibodies.
Topics: Alkylating Agents; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine- | 2006 |
[Ocular involvement in MuSK antibody-positive myasthenia gravis].
Topics: Adult; Autoantibodies; Autoimmune Diseases; Azathioprine; Drug Therapy, Combination; Female; Humans; | 2006 |
Guidelines for the treatment of autoimmune neuromuscular transmission disorders.
Topics: Adrenal Cortex Hormones; Autoimmune Diseases of the Nervous System; Azathioprine; Humans; Immunosupp | 2006 |
Myasthenia gravis in children: a longitudinal study.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Age Distribution; Age of Onset; Azathioprine; Child; Chi | 2006 |
Persistence of CD16+/CD56-/2B4+ natural killer cells: a highly dysfunctional NK subset expanded in ocular myasthenia gravis.
Topics: Aged; Anti-Inflammatory Agents; Antigens, CD; Azathioprine; CD56 Antigen; Cholinesterase Inhibitors; | 2006 |
Safety of long-term combined immunosuppressive treatment in myasthenia gravis--analysis of adverse effects of 163 patients.
Topics: Azathioprine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Longitudinal Stud | 2006 |
Risk of malignancy in myasthenia gravis patients exposed to azathioprine therapy for a median period of 3 years.
Topics: Adult; Azathioprine; Dose-Response Relationship, Drug; Female; Humans; Immunosuppressive Agents; Inc | 2006 |
Thymectomy in the treatment of myasthenia.
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Aged; Azathioprine; Cholinesterase Inhibitors; Evalu | 1980 |
Reversal of apparent premature ovarian failure in a patient with myasthenia gravis.
Topics: Adult; Azathioprine; Estrogens, Conjugated (USP); Female; Humans; Menstruation Disturbances; Myasthe | 1983 |
Time course of improved neuromuscular function following plasma exchange alone and plasma exchange with prednisone/azathioprine in myasthenia gravis.
Topics: Adult; Aged; Autoantibodies; Azathioprine; Brachial Plexus; Electric Stimulation; Female; Humans; Ma | 1982 |
Absence of decremental response in decentralized muscles of a myasthenic patient.
Topics: Aged; Azathioprine; Drug Therapy, Combination; Female; Humans; Myasthenia Gravis; Neuromuscular Junc | 1983 |
[Amount of circulating acetylcholine receptor antibodies in the course of myasthenia, following thymectomy and in immunosuppressive therapy].
Topics: Adult; Autoantibodies; Azathioprine; Drug Therapy, Combination; Female; Humans; Male; Myasthenia Gra | 1984 |
Plasma exchange in myasthenia gravis.
Topics: Adolescent; Adult; Aged; Azathioprine; Cholinesterase Inhibitors; Evaluation Studies as Topic; Femal | 1984 |
[Correlation of acetylcholine receptor antibodies and clinical severity of myasthenia gravis in combined immunosuppressive therapy].
Topics: Adult; Autoantibodies; Azathioprine; Combined Modality Therapy; Dose-Response Relationship, Drug; Dr | 1984 |
Hypersensitivity to azathioprine in myasthenia gravis.
Topics: Azathioprine; Drug Hypersensitivity; Humans; Male; Mercaptopurine; Middle Aged; Myasthenia Gravis | 1984 |
[Antibody-controlled cytostatic therapy of malignant thymoma with concomitant myasthenia gravis].
Topics: Acetylcholine; Antibodies; Antineoplastic Combined Chemotherapy Protocols; Azathioprine; Cyclophosph | 1984 |
Azathioprine in the treatment of myasthenia gravis.
Topics: Adult; Aged; Azathioprine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Huma | 1984 |
[Haematological changes following long-term treatment of multiple sclerosis and myasthenia with azathioprin (author's transl)].
Topics: Azathioprine; Erythrocyte Count; Erythrocyte Indices; Hemoglobinometry; Humans; Leukocyte Count; Lon | 1982 |
Anti-acetylcholine receptor antibodies in myasthenia gravis. Part 2. Clinical and serological follow-up of individual patients.
Topics: Adolescent; Adult; Aged; Autoantibodies; Azathioprine; Child; Chlorambucil; Female; Humans; Male; Mi | 1983 |
Effect of immunosuppressive drugs (azathioprine).
Topics: Adult; Azathioprine; Humans; Myasthenia Gravis; Prednisone; Thymectomy | 1981 |
Response to plasmapheresis and immunosuppressive drug therapy in sixty myasthenia gravis patients.
Topics: Adult; Aged; Azathioprine; Cyclophosphamide; Female; Humans; Immunosuppressive Agents; Male; Middle | 1981 |
Plasmapheresis: a new treatment modality for the patient with severe myasthenia gravis.
Topics: Azathioprine; Cholinesterase Inhibitors; Humans; Male; Middle Aged; Myasthenia Gravis; Plasmapheresi | 1982 |
Plasmapheresis in myasthenia gravis.
Topics: Adult; Aged; Autoantibodies; Azathioprine; Chlorambucil; Cyclophosphamide; Female; Humans; Immunosup | 1982 |
[Myelosuppression with macrocytic anaemia and leucopenia during treatment with azathioprine in myasthenia gravis].
Topics: Allopurinol; Anemia, Macrocytic; Azathioprine; Drug Interactions; Female; Humans; Leukopenia; Middle | 1982 |
Plasma exchange combined with cytotoxic drugs and lymphocytapheresis for myasthenia gravis.
Topics: Azathioprine; Cell Separation; Cyclophosphamide; Female; Humans; Immunosuppressive Agents; Leukapher | 1982 |
The role of plasma exchange in treatment of myasthenia gravis.
Topics: Adrenal Cortex Hormones; Adult; Aged; Autoantibodies; Azathioprine; Female; Humans; Immunoglobulin G | 1982 |
[Comments on the indication of immunosuppressive long-term therapy in myasthenia gravis (author's transl)].
Topics: Azathioprine; Bone Marrow Diseases; Cholestasis, Intrahepatic; Cholinesterase Inhibitors; Humans; Jo | 1981 |
Plasmapheresis in refractory generalized myasthenia gravis.
Topics: Adult; Aged; Antibodies; Azathioprine; Cholinesterases; Female; Humans; Male; Middle Aged; Myastheni | 1981 |
Plasma exchange and immunosuppressive drug treatment in myasthenia gravis: no evidence for synergy.
Topics: Adolescent; Adult; Aged; Autoantibodies; Azathioprine; Cyclophosphamide; Cytarabine; Female; Humans; | 1981 |
Immune regulation of experimental myasthenia.
Topics: Acetylcholine; Adrenal Cortex Hormones; Animals; Antibody Formation; Autoimmune Diseases; Azathiopri | 1980 |
Anti-acetylcholine receptor antibody titres in the sera of myasthenia patients treated with plasma exchange combined with immunosuppressive therapy.
Topics: Acetylcholine; Adult; Aged; Antibodies; Azathioprine; Female; Humans; Immunosuppression Therapy; Mal | 1980 |
[Treatment of myasthenia gravis--pathophysiological evaluation of various forms of treatment and practical aspects of therapy (author's transl)].
Topics: Azathioprine; Cholinesterase Inhibitors; Evaluation Studies as Topic; Humans; Myasthenia Gravis; Pla | 1980 |
Thymectomy and azathioprine have no effect on the phenotype of CD4 T lymphocyte subsets in myasthenia gravis.
Topics: Adolescent; Adult; Aged; Azathioprine; CD4-Positive T-Lymphocytes; Female; Fluorescent Antibody Tech | 1993 |
[Bronchiolo-alveolar carcinoma complicating myasthenia treated by azathioprine].
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Azathioprine; Hemorrhage; Humans; Lung Diseases; Lung Neoplasms | 1993 |
Azathioprine as a single immunosuppressive drug in the treatment of myasthenia gravis.
Topics: Adolescent; Adult; Aged; Azathioprine; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; | 1993 |
Relapses in patients with myasthenia gravis treated with azathioprine.
Topics: Azathioprine; Chronic Disease; Humans; Middle Aged; Myasthenia Gravis; Time Factors | 1993 |
Immunosuppressive treatments. Their efficacy on myasthenia gravis patients' outcome and on the natural course of the disease.
Topics: Adrenal Cortex Hormones; Azathioprine; Follow-Up Studies; Humans; Immunosuppression Therapy; Myasthe | 1993 |
Lymphocytapheresis in combination with immunosuppressive drugs for refractory myasthenia gravis: two-color flow cytometric analysis of changes in peripheral blood lymphocyte subsets.
Topics: Autoantibodies; Azathioprine; Combined Modality Therapy; Drug Therapy, Combination; Female; Flow Cyt | 1995 |
Memory in myasthenia gravis: neuropsychological tests of central cholinergic function before and after effective immunologic treatment.
Topics: Adolescent; Adult; Aged; Azathioprine; Brain; Female; Humans; Immunosuppression Therapy; Male; Memor | 1996 |
[A post-thymomectomy case of myasthenia gravis which developed nephrotic syndrome with membranous nephropathy during azathioprine administration].
Topics: Azathioprine; Combined Modality Therapy; Female; Glomerulonephritis, Membranous; Glucocorticoids; Hu | 1996 |
Ocular myasthenia gravis: response to long-term immunosuppressive treatment.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Autoimmune Diseases; Azathioprine; Child; Drug Administr | 1997 |
Myasthenia gravis: diagnosis and follow-up of 100 consecutive patients.
Topics: Age of Onset; Aged; Autoimmune Diseases; Azathioprine; Cholinesterase Inhibitors; Cohort Studies; Di | 1997 |
[Myasthenic crisis caused by azathioprine-induced fever].
Topics: Aged; Azathioprine; Critical Care; Drug Hypersensitivity; Drug Therapy, Combination; Fever; Humans; | 1997 |
Outcome in juvenile-onset myasthenia gravis: a retrospective study with long-term follow-up of 79 patients.
Topics: Adolescent; Antibodies; Azathioprine; Child; Drug Combinations; Female; Follow-Up Studies; Glucocort | 1997 |
Late onset immunodeficiency in a patient with recurrent thymic carcinoma and myasthenia gravis.
Topics: Adult; Age Factors; Azathioprine; Carcinoma; CD4-Positive T-Lymphocytes; Female; Humans; Immunologic | 1998 |
[Treatment of myasthenia: role of corticoids and immunosuppressive agents].
Topics: Acute Disease; Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents; Azathioprine; Cyclosporins; | 1999 |
[Myasthenia gravis. Opportunistic cytomegalovirus infection after long-term azathioprine therapy].
Topics: Azathioprine; Cytomegalovirus Infections; Female; Humans; Immunosuppressive Agents; Long-Term Care; | 1999 |
Immunosuppressive treatment of rippling muscles in patients with myasthenia gravis.
Topics: Adult; Azathioprine; Humans; Immunosuppressive Agents; Male; Middle Aged; Muscle Contraction; Muscul | 1999 |
Association of primary central nervous system lymphoma with long-term azathioprine therapy for myasthenia gravis?
Topics: Aged; Azathioprine; Central Nervous System Neoplasms; Humans; Immunosuppressive Agents; Lymphoma; Mi | 2000 |
Myasthenia gravis with a paraneoplastic marker.
Topics: Autoantibodies; Azathioprine; Biomarkers; Blepharoptosis; Calcium Channels; Carcinoma, Large Cell; D | 2000 |
Clinical characteristics and prognosis of myasthenia gravis in older people.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Azathioprine; Cholinesterase Inhibitors; Drug The | 2000 |
Effect of thymectomy on human peripheral blood T cell pools in myasthenia gravis.
Topics: Adolescent; Adult; Azathioprine; CD4-CD8 Ratio; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocyt | 2001 |
Analysis of thymectomy for myasthenia gravis in older patients: a 20-year single institution experience.
Topics: Adolescent; Adult; Age Factors; Aged; Azathioprine; Child; Child, Preschool; Combined Modality Thera | 2001 |
High-dose immunosuppressive therapy in generalised myasthenia gravis--a 2-year follow-up study.
Topics: Anti-Inflammatory Agents; Azathioprine; Dose-Response Relationship, Drug; Drug Administration Schedu | 2001 |
Prognostic factors of thymectomy in patients with myasthenia gravis: a cohort of 132 patients.
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Case-Control Studies; Dose-Response Relationship, Drug | 2001 |
Presentation of myasthenia gravis mimicking blepharospasm.
Topics: Aged; Azathioprine; Blepharospasm; Cholinesterase Inhibitors; Diagnostic Errors; Electromyography; G | 2002 |
Remission of myasthenia gravis following plasma-exchange.
Topics: Adult; Autoantibodies; Autoimmune Diseases; Azathioprine; Cyclophosphamide; Evaluation Studies as To | 1976 |
Long-term effects of repeated plasma exchange in myasthenia gravis.
Topics: Acetylcholine; Adolescent; Adult; Antibody Formation; Autoantibodies; Autoimmune Diseases; Azathiopr | 1979 |
Plasma-exchange combined with immunosuppressive therapy in myasthenia gravis.
Topics: Adult; Aged; Azathioprine; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myasthenia Gravis; | 1979 |
Combined plasma exchange and immunosuppression in myasthenia gravis.
Topics: Azathioprine; Follow-Up Studies; Humans; Male; Myasthenia Gravis; Plasmapheresis; Prednisone; Time F | 1979 |
Drainage of thoracic duct lymph in twelve patients with myasthenia gravis.
Topics: Adrenocorticotropic Hormone; Adult; Azathioprine; Cholinesterase Inhibitors; Drainage; Female; Follo | 1975 |
Effects of some immunosuppressive procedures on myasthenia gravis.
Topics: Adrenocorticotropic Hormone; Animals; Azathioprine; B-Lymphocytes; Betamethasone; Chromosome Mapping | 1976 |
[Therapy of myasthenia (author's transl)].
Topics: Adrenocorticotropic Hormone; Azathioprine; Female; Humans; Infant, Newborn; Infant, Newborn, Disease | 1976 |
Antibodies against human cholinergic receptor proteins in patients with myasthenia gravis: Studies during immunosuppressive treatment. Preliminary report.
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Azathioprine; Binding Sites, Antibody; Humans; | 1977 |
[Therapy of myasthenia gravis].
Topics: Adrenocorticotropic Hormone; Azathioprine; Cholinesterase Inhibitors; Drainage; Humans; Immunosuppre | 1977 |
Determination of acetylcholine receptor antibody in myasthenia gravis: clinical usefulness and pathogenetic implications.
Topics: Adrenocorticotropic Hormone; Antibodies; Azathioprine; Drainage; Humans; Immunoglobulin G; Immunoglo | 1978 |
[Immunologic aspects of the pathogenesis and treatment of myasthenia].
Topics: Adrenocorticotropic Hormone; Adult; Aged; Antilymphocyte Serum; Autoantibodies; Azathioprine; B-Lymp | 1979 |
Symposium on therapeutic controversies. Myasthenia gravis. Steroids and immunosuppressive drugs.
Topics: Adrenocorticotropic Hormone; Aged; Azathioprine; Humans; Myasthenia Gravis; Prednisone | 1978 |
[Side-effects of azathioprine and cyclophosphamide therapy].
Topics: Azathioprine; Cyclophosphamide; Humans; Myasthenia Gravis | 1979 |
[Problems of postthymectomy-syndromes, e.g. myasthenia gravis (author's transl)].
Topics: Adult; Antibodies, Antinuclear; Azathioprine; Humans; Male; Middle Aged; Myasthenia Gravis; Pyridost | 1977 |
[Treatment of myasthenia gravis with plasmapheresis (author's transl)].
Topics: Adolescent; Adult; Azathioprine; Cyclophosphamide; Female; Humans; Male; Middle Aged; Myasthenia Gra | 1979 |
Bartter's syndrome associated with Graves' disease and myasthenia gravis: report of a case.
Topics: Adult; Aldosterone; Angiotensin II; Azathioprine; Bartter Syndrome; Blood Pressure; Graves Disease; | 1978 |
[A case of thymoma with myasthenia gravis and pure red cell aplasia treated with thymectomy and azathioprine (author's transl)].
Topics: Aged; Anemia, Aplastic; Azathioprine; Humans; Male; Myasthenia Gravis; Thymectomy; Thymoma; Thymus N | 1978 |
[Myasthenia gravis. Longitudinal course and therapeutic aspects].
Topics: Adult; Azathioprine; Cholinesterase Inhibitors; Cosyntropin; Drug Therapy, Combination; Enzyme Inhib | 1978 |
Immunosuppression of experimental autoimmune myasthenia gravis by azathioprine. II. Evaluation of immunological mechanism.
Topics: Animals; Antigens; Autoimmune Diseases; Azathioprine; Immunosuppressive Agents; In Vitro Techniques; | 1977 |
[2 current topics from the field of psychiatry and neurology].
Topics: Adult; Azathioprine; Electroencephalography; Epilepsy; Female; Humans; Multiple Sclerosis; Myastheni | 1977 |
Plasmapheresis and immunosuppressive drug therapy in myasthenia gravis.
Topics: Acetylcholine; Adult; Autoantibodies; Azathioprine; Female; Humans; Male; Middle Aged; Myasthenia Gr | 1977 |
Immunosuppression of experimental autoimmune myasthenia gravis by hydrocortisone and azathioprine.
Topics: Acetylcholine; Animals; Autoimmune Diseases; Azathioprine; Dose-Response Relationship, Drug; Female; | 1976 |
[New findings on the pathogenesis and therapy of myasthenia].
Topics: Acetylcholine; Autoimmune Diseases; Azathioprine; Cortisone; Humans; Myasthenia Gravis | 1976 |
[Therapy of pseudoparalytic myasthenia gravis].
Topics: Ambenonium Chloride; Azathioprine; Humans; Myasthenia Gravis; Neostigmine; Pyridostigmine Bromide; T | 1975 |
[Letter: Therapy of myasthenia gravis pseudoparalytica].
Topics: Azathioprine; Humans; Myasthenia Gravis; Pyridostigmine Bromide; Thymectomy | 1976 |
Myasthenia gravis and steroid-induced myopathy of the respiratory muscles.
Topics: Adrenal Cortex Hormones; Adult; Atrophy; Azathioprine; Electromyography; Female; Humans; Lung Volume | 1992 |
Immunosuppressive treatment for juvenile myasthenia gravis.
Topics: Adolescent; Adult; Autoimmune Diseases; Azathioprine; Child; Cyclophosphamide; Female; Humans; Immun | 1992 |
[Possibilities of using enterosorption in the treatment of myasthenia gravis].
Topics: Adolescent; Adult; Azathioprine; Charcoal; Child; Combined Modality Therapy; Enterosorption; Eye Mov | 1991 |
[Myasthenia gravis: clinical and surgical treatment].
Topics: Adrenal Cortex Hormones; Azathioprine; Female; Humans; Male; Myasthenia Gravis; Plasmapheresis; Pyri | 1991 |
Effect of thymectomy and immunosuppressive therapy on anti-neuroblastoma antibody levels in patients with myasthenia gravis.
Topics: Adolescent; Adult; Aged; Autoantibodies; Azathioprine; Cell Line; Female; Follow-Up Studies; Humans; | 1991 |
Thymectomy and azathioprine in the treatment of type 1 (insulin-dependent) diabetes mellitus.
Topics: Adult; Azathioprine; Combined Modality Therapy; Diabetes Mellitus, Type 1; Female; Humans; Myastheni | 1990 |
Long term treatment of myasthenia gravis with azathioprine.
Topics: Adult; Azathioprine; Drug Therapy, Combination; Female; Humans; Hypertension, Portal; Jaundice; Long | 1990 |
[Abscess of the thyroid gland caused by Salmonella enteritidis in immunosuppressive treatment of generalized myasthenia gravis with thymoma].
Topics: Abscess; Aged; Azathioprine; Humans; Middle Aged; Myasthenia Gravis; Opportunistic Infections; Risk | 1990 |
[Treatment of invasive thymoma with myasthenia gravis: a case report responsive to azathioprine and methylprednisolone].
Topics: Adult; Azathioprine; Drug Therapy, Combination; Humans; Male; Methylprednisolone; Myasthenia Gravis; | 1990 |
[A case of simultaneous occurrence of myasthenia gravis and multiple sclerosis].
Topics: Adult; Autoantibodies; Azathioprine; Diagnosis, Differential; Evoked Potentials, Visual; Humans; Imm | 1990 |
Antibody-mediated pure neutrophil aplasia, recurrent myasthenia gravis and previous thymoma: case report and literature review.
Topics: Adult; Agranulocytosis; Antibodies; Azathioprine; Bone Marrow; Female; Humans; Immunosuppression The | 1990 |
The relationship of age to outcome in myasthenia gravis.
Topics: Adrenal Cortex Hormones; Aged; Aging; Antibodies; Autoimmune Diseases; Azathioprine; Combined Modali | 1990 |
Antibody response to pneumococcal polysaccharide vaccine in myasthenia gravis: effect of therapeutic plasmapheresis.
Topics: Adult; Aged; Antibodies, Bacterial; Antigens, Bacterial; Azathioprine; Bacterial Vaccines; Combined | 1990 |
[Thymectomy and immunosuppression in myasthenia gravis: a prospective study].
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Azathioprine; Child; Combined Modality Therapy; Fe | 1990 |
Unsuspected myasthenia gravis presenting as respiratory failure.
Topics: Azathioprine; Humans; Male; Middle Aged; Myasthenia Gravis; Prednisolone; Respiratory Insufficiency | 1990 |
Azathioprine as possible explanation of etiology of pure red cell aplasia in myasthenics.
Topics: Adult; Azathioprine; Female; Humans; Myasthenia Gravis; Red-Cell Aplasia, Pure; Thymoma | 1989 |
[Tactics in the management of pregnancy and labor in myasthenia gravis].
Topics: Adult; Azathioprine; Cholinesterase Inhibitors; Combined Modality Therapy; Delivery, Obstetric; Fema | 1989 |
[Immunodepressive agents in neurology].
Topics: Adrenal Cortex Hormones; Antilymphocyte Serum; Azathioprine; Cyclophosphamide; Dermatomyositis; Huma | 1986 |
Long-term treatment with azathioprine abolishes thymic lymphoid follicular hyperplasia in myasthenia gravis.
Topics: Azathioprine; Humans; Long-Term Care; Myasthenia Gravis; Thymectomy; Thymus Hyperplasia | 1987 |
Azathioprine and myasthenia gravis.
Topics: Azathioprine; Female; Humans; Mediastinum; Myasthenia Gravis; Thymectomy; Time Factors | 1987 |
Therapeutic immunoadsorption of acetylcholine receptor antibodies in myasthenia gravis.
Topics: Autoantibodies; Azathioprine; Humans; Immunosorbent Techniques; Immunotherapy; Myasthenia Gravis; Pl | 1988 |
[Intensive therapy of myasthenia gravis].
Topics: Azathioprine; Combined Modality Therapy; Critical Care; Humans; Infusion Pumps; Male; Middle Aged; M | 1988 |
[The prognosis of juvenile myasthenia gravis].
Topics: Adolescent; Autoantibodies; Azathioprine; Child; Child, Preschool; Cholinesterase Inhibitors; Female | 1988 |
Myasthenia gravis: discontinuation of long-term azathioprine.
Topics: Azathioprine; Follow-Up Studies; Humans; Myasthenia Gravis; Recurrence | 1988 |
Portal hypertension secondary to azathioprine in myasthenia gravis.
Topics: Azathioprine; Humans; Hypertension, Portal; Liver; Male; Middle Aged; Myasthenia Gravis | 1988 |
Azathioprine toxicity during long-term immunosuppression of generalized myasthenia gravis.
Topics: Aged; Aged, 80 and over; Azathioprine; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; | 1988 |
Myasthenia gravis treatment: twelve years experience on 110 patients.
Topics: Azathioprine; Combined Modality Therapy; Dexamethasone; Humans; Immunosuppressive Agents; Myasthenia | 1987 |
The course of myasthenia gravis in patients treated with corticosteroids, azathioprine, and plasmapheresis.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Azathioprine; Combined Modality | 1987 |
Immunosuppressive drugs: azathioprine in the treatment of myasthenia gravis.
Topics: Azathioprine; Bone Marrow Diseases; Drug Evaluation; Female; Gastrointestinal Diseases; Humans; Male | 1987 |
Myasthenia gravis and pregnancy.
Topics: Adrenal Cortex Hormones; Azathioprine; Cholinesterase Inhibitors; Female; Humans; Infant, Newborn; M | 1987 |
Factors influencing the relapse risk at steroid dose reduction in myasthenia gravis.
Topics: Azathioprine; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Myasthenia Gravis; | 1987 |
Listeria meningitis complicating treatment of myasthenia gravis with azathioprine and steroids.
Topics: Aged; Azathioprine; Female; Humans; Meningitis, Listeria; Myasthenia Gravis; Steroids | 1986 |
Monitoring azathioprine therapy in myasthenia gravis.
Topics: Azathioprine; Erythrocyte Indices; Humans; Monitoring, Physiologic; Myasthenia Gravis | 1986 |
[Value of acetylcholine receptor antibodies in myasthenia gravis].
Topics: Adult; Autoantibodies; Azathioprine; Cortisone; Female; Follow-Up Studies; Humans; Male; Myasthenia | 1986 |
[Treatment of myasthenia gravis by immunosuppressive non-steroidal drugs].
Topics: Adolescent; Adult; Aged; Azathioprine; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; | 1986 |
Myasthenia gravis: reactivation of clinical disease and of autoimmune factors after discontinuation of long-term azathioprine.
Topics: Adult; Aged; Autoantibodies; Azathioprine; Female; Humans; Immunity, Cellular; Male; Middle Aged; My | 1985 |
Azathioprine experience in severe, generalized, recalcitrant myasthenia gravis.
Topics: Adult; Aged; Azathioprine; Female; Humans; Male; Middle Aged; Myasthenia Gravis | 1985 |
Immunosuppressive drug therapy in myasthenia gravis.
Topics: Adolescent; Adult; Aged; Azathioprine; Child; Cyclophosphamide; Female; Humans; Male; Middle Aged; M | 1986 |
[Therapy of myasthenia gravis].
Topics: Adrenal Cortex Hormones; Azathioprine; Cholinesterase Inhibitors; Cyclophosphamide; Humans; Myasthen | 1986 |
[Ocular myasthenia].
Topics: Azathioprine; Blepharoptosis; Cholinesterase Inhibitors; Cortisone; Cyclophosphamide; Electromyograp | 1985 |
Short and long-term clinical effects of plasma-exchange in 33 cases of myasthenia gravis.
Topics: Adolescent; Adult; Aged; Azathioprine; Child; Cholinesterase Inhibitors; Female; Humans; Male; Middl | 1985 |
Adrenergic blockade in hypertension.
Topics: Autoimmune Diseases; Azathioprine; Dyspnea; Female; Hepatitis; Humans; Middle Aged; Myasthenia Gravi | 1972 |
Azathioprine for myasthenia gravis.
Topics: Azathioprine; Chronic Disease; Hepatitis; Humans; Immunologic Deficiency Syndromes; Myasthenia Gravi | 1972 |
Synergistic immunosuppressive action of antithymocyte antisera and thymectomy in the human.
Topics: Adolescent; Adult; Aged; Animals; Antibody Formation; Antilymphocyte Serum; Azathioprine; Blood Sedi | 1972 |
The treatment of severe myasthenia gravis with immunosuppressive agents.
Topics: Adolescent; Adult; Age Factors; Agranulocytosis; Aminopterin; Azathioprine; Chemical and Drug Induce | 1969 |
[Preliminary observations of the treatment of myasthenia by azathioprine].
Topics: Adrenocorticotropic Hormone; Adult; Antibodies; Autoimmune Diseases; Azathioprine; Female; Humans; M | 1967 |
Treatment of myasthenia--I.
Topics: Adrenocorticotropic Hormone; Azathioprine; Bronchial Neoplasms; Carcinoma; Cholinesterase Inhibitors | 1971 |
[Current results of the treatment of pseudoparalytic myasthenia gravis with immunosuppressive agents].
Topics: Adrenocorticotropic Hormone; Adult; Antibodies; Antilymphocyte Serum; Azathioprine; Cholinesterase I | 1972 |
The effect of thoracic duct lymph drainage in myasthenia gravis.
Topics: Adrenocorticotropic Hormone; Adult; Azathioprine; Cholinesterase Inhibitors; Drainage; Evaluation St | 1973 |
[Treatment of myasthenia gravis].
Topics: Adrenocorticotropic Hormone; Azathioprine; Cholinesterase Inhibitors; Drainage; Electromyography; Fe | 1973 |
Cell-mediated immunity in polymyositis. Creatine phosphokinase release from muscle cultures.
Topics: Adolescent; Adult; Aged; Autoimmune Diseases; Azathioprine; Child; Creatine Kinase; Culture Techniqu | 1974 |
Immunosurveillance and cancer: epidemiological evidence.
Topics: Adolescent; Adult; Age Factors; Aged; Azathioprine; Chediak-Higashi Syndrome; Child; Child, Preschoo | 1970 |
Effect of 'maximum immune suppression' with thoracic duct drainage, ALG, azathioprine and cortisone in some neurological disorders.
Topics: Antilymphocyte Serum; Autoimmune Diseases; Azathioprine; Central Nervous System Diseases; Cortisone; | 1972 |
[Anemia caused by erythroblastopenia in adult age].
Topics: Aged; Analgesics; Anemia, Aplastic; Azathioprine; Blood Transfusion; Female; Heart Failure; Hepatiti | 1970 |
Immunosuppressive drugs in treatment of myasthenia gravis.
Topics: Adult; Autoimmune Diseases; Azathioprine; Blood Cell Count; Busulfan; Cyclophosphamide; Female; Huma | 1971 |
Myasthenia gravis. A clinical analysis of the total material from Finland with special reference to endocrinological and neurological disorders.
Topics: Age Factors; Ambenonium Chloride; Azathioprine; Cortisone; Diabetes Complications; Disability Evalua | 1969 |
[Thymectomy in myasthenia gravis].
Topics: Adolescent; Adult; Azathioprine; Female; Humans; Male; Myasthenia Gravis; Thymectomy | 1969 |
Effect on mice of intravenous administration of lymphocytes from normal subjects and from patients with myasthenia gravis.
Topics: Adult; Animals; Azathioprine; Female; Graft vs Host Disease; Growth; Humans; Injections, Intravenous | 1969 |